| 1 |
Copur MS, Tun SM, Vargas L, Merani S, Wedel W, Duckert R, Horn A, Lintel N, Herold D, Lavudi S. Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.10.002] [Reference Citation Analysis]
|
| 2 |
Chapin WJ, Reiss KA. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am 2022:S0889-8588(22)00075-2. [PMID: 36154785 DOI: 10.1016/j.hoc.2022.07.007] [Reference Citation Analysis]
|
| 3 |
Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment. Eur J Cancer 2022;175:136-57. [PMID: 36115290 DOI: 10.1016/j.ejca.2022.07.020] [Reference Citation Analysis]
|
| 4 |
Kole C, Charalampakis N, Tsakatikas S, Frountzas M, Apostolou K, Schizas D. Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. CMAR 2022;Volume 14:1043-61. [DOI: 10.2147/cmar.s267260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Ganguly S, Ghanem A, Mian OY. DNA damage, metabolism, and epigenetic regulation. Epigenetics and DNA Damage 2022. [DOI: 10.1016/b978-0-323-91081-1.00001-7] [Reference Citation Analysis]
|
| 6 |
Yen YT, Chien M, Wu PY, Ho CC, Ho CT, Huang KC, Chiang SF, Chao KSC, Chen WT, Hung SC. Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response. Nat Commun 2021;12:7297. [PMID: 34911954 DOI: 10.1038/s41467-021-27620-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Susanti S, Wibowo S, Akbariani G, Yoshuantari N, Heriyanto DS, Ridwanuloh AM, Hariyatun H, Handaya AY, Kurnianda J, Hutajulu SH, Ilyas M. Molecular Analysis of Colorectal Cancers Suggests a High Frequency of Lynch Syndrome in Indonesia. Cancers 2021;13:6245. [DOI: 10.3390/cancers13246245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Oneda E, Zaniboni A. Adjuvant treatment of colon cancer with microsatellite instability - the state of the art. Crit Rev Oncol Hematol 2021;169:103537. [PMID: 34801698 DOI: 10.1016/j.critrevonc.2021.103537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Roudko V, Cimen Bozkus C, Greenbaum B, Lucas A, Samstein R, Bhardwaj N. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines. Front Immunol 2021;12:757804. [PMID: 34630437 DOI: 10.3389/fimmu.2021.757804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Gebert J, Gelincik O, Oezcan-Wahlbrink M, Marshall JD, Hernandez-Sanchez A, Urban K, Long M, Cortes E, Tosti E, Katzenmaier EM, Song Y, Elsaadi A, Deng N, Vilar E, Fuchs V, Nelius N, Yuan YP, Ahadova A, Sei S, Shoemaker RH, Umar A, Wei L, Liu S, Bork P, Edelmann W, von Knebel Doeberitz M, Lipkin SM, Kloor M. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model. Gastroenterology 2021;161:1288-1302.e13. [PMID: 34224739 DOI: 10.1053/j.gastro.2021.06.073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 11 |
Jasmine F, Haq Z, Kamal M, Raza M, da Silva G, Gorospe K, Paul R, Strzempek P, Ahsan H, Kibriya MG. Interaction between Microsatellite Instability (MSI) and Tumor DNA Methylation in the Pathogenesis of Colorectal Carcinoma. Cancers (Basel) 2021;13:4956. [PMID: 34638440 DOI: 10.3390/cancers13194956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Lorzadeh A, Romero-Wolf M, Goel A, Jadhav U. Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation. Gastroenterology 2021;160:2267-82. [PMID: 33775639 DOI: 10.1053/j.gastro.2021.03.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Guyot D'Asnières De Salins A, Tachon G, Cohen R, Karayan-Tapon L, Junca A, Frouin E, Godet J, Evrard C, Randrian V, Duval A, Svrcek M, Lascols O, Vignot S, Coulet F, André T, Fléjou JF, Cervera P, Tougeron D. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer. ESMO Open 2021;6:100120. [PMID: 33930657 DOI: 10.1016/j.esmoop.2021.100120] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 14 |
Fountzilas E, Kurzrock R, Vo HH, Tsimberidou AM. Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker. J Natl Cancer Inst 2021;113:1634-47. [PMID: 33823006 DOI: 10.1093/jnci/djab067] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 15 |
Shrestha KS, Tuominen MM, Kauppi L. Mlh1 heterozygosity and promoter methylation associates with microsatellite instability in mouse sperm. Mutagenesis 2021;36:237-44. [PMID: 33740045 DOI: 10.1093/mutage/geab010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res 2021;151:425-68. [PMID: 34148620 DOI: 10.1016/bs.acr.2021.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 17 |
Wu Q, Huang Y, Gu L, Chang Z, Li GM. OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitination. J Biol Chem 2021;296:100466. [PMID: 33640455 DOI: 10.1016/j.jbc.2021.100466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Grady WM, Yu M, Markowitz SD. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021;160:690-709. [PMID: 33279516 DOI: 10.1053/j.gastro.2020.09.058] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 19 |
Zardo G. The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer. Biomolecules 2021;11:143. [PMID: 33499170 DOI: 10.3390/biom11020143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Roudko V, Bozkus CC, Orfanelli T, McClain CB, Carr C, O'Donnell T, Chakraborty L, Samstein R, Huang KL, Blank SV, Greenbaum B, Bhardwaj N. Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors. Cell 2020;183:1634-1649.e17. [PMID: 33259803 DOI: 10.1016/j.cell.2020.11.004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 21 |
Chang SC, Li AF, Lin PC, Lin CC, Lin HH, Huang SC, Lin CH, Liang WY, Chen WS, Jiang JK, Lin JK, Yang SH, Lan YT. Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP). Cancers (Basel) 2020;12:E3487. [PMID: 33238621 DOI: 10.3390/cancers12113487] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Chen X, Yang Z, Feng J, Duan T, Pan T, Yan L, Jin T, Xiang Y, Zhang M, Chen P, Wang W, Zhang R, Chen B, Zhao L, Xie T, Sui X. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer. Cancer Med 2021;10:317-24. [PMID: 33174323 DOI: 10.1002/cam4.3602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Kole C, Charalampakis N, Tsakatikas S, Vailas M, Moris D, Gkotsis E, Kykalos S, Karamouzis MV, Schizas D. Immunotherapy for Hepatocellular Carcinoma: A 2021 Update. Cancers (Basel) 2020;12:E2859. [PMID: 33020428 DOI: 10.3390/cancers12102859] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 24 |
Bläker H, Haupt S, Morak M, Holinski-Feder E, Arnold A, Horst D, Sieber-Frank J, Seidler F, von Winterfeld M, Alwers E, Chang-Claude J, Brenner H, Roth W, Engel C, Löffler M, Möslein G, Schackert HK, Weitz J, Perne C, Aretz S, Hüneburg R, Schmiegel W, Vangala D, Rahner N, Steinke-Lange V, Heuveline V, von Knebel Doeberitz M, Ahadova A, Hoffmeister M, Kloor M; German Consortium for Familial Intestinal Cancer. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics. Int J Cancer 2020;147:2801-10. [PMID: 32875553 DOI: 10.1002/ijc.33273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 25 |
Jansen AML, Goel A. Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: A Systematic Review. Clin Gastroenterol Hepatol 2020;18:1949-60. [PMID: 32147591 DOI: 10.1016/j.cgh.2020.02.049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 26 |
Bohaumilitzky L, von Knebel Doeberitz M, Kloor M, Ahadova A. Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review. J Clin Med 2020;9:E1741. [PMID: 32512823 DOI: 10.3390/jcm9061741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1214. [PMID: 32413973 DOI: 10.3390/cancers12051214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 28 |
Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation. Cancer Epidemiol Biomarkers Prev 2020;29:2431-40. [PMID: 32299850 DOI: 10.1158/1055-9965.EPI-20-0234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Schizas D, Charalampakis N, Kole C, Economopoulou P, Koustas E, Gkotsis E, Ziogas D, Psyrri A, Karamouzis MV. Immunotherapy for pancreatic cancer: A 2020 update.Cancer Treat Rev. 2020;86:102016. [PMID: 32247999 DOI: 10.1016/j.ctrv.2020.102016] [Cited by in Crossref: 163] [Cited by in F6Publishing: 163] [Article Influence: 54.3] [Reference Citation Analysis]
|
| 30 |
Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
|
| 31 |
Kreidieh M, Mukherji D, Temraz S, Shamseddine A. Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions. Biomed Res Int 2020;2020:9037217. [PMID: 32090113 DOI: 10.1155/2020/9037217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 32 |
Rasool M, Pushparaj PN, Mirza Z, Imran Naseer M, Abusamra H, Alquaiti M, Shaabad M, Sibiany AMS, Gauthaman K, Al-Qahtani MH, Karim S. Array comparative genomic hybridization based identification of key genetic alterations at 2p21-p16.3 (MSH2, MSH6, EPCAM), 3p23-p14.2 (MLH1), 7p22.1 (PMS2) and 1p34.1-p33 (MUTYH) regions in hereditary non polyposis colorectal cancer (Lynch syndrome) in the Kingdom of Saudi Arabia. Saudi J Biol Sci 2020;27:157-62. [PMID: 31889830 DOI: 10.1016/j.sjbs.2019.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 33 |
Makhdoomi RH, Khurshid SU, Shah BM. Pathology in Colorectal Malignancy. New Treatment Modalities in Rectal Cancer 2020. [DOI: 10.1007/978-981-13-7197-4_6] [Reference Citation Analysis]
|
| 34 |
Mardis ER. Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response. Genome Med 2019;11:71. [PMID: 31747945 DOI: 10.1186/s13073-019-0684-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 35 |
Kim DG, An JY, Kim H, Shin SJ, Choi S, Seo WJ, Roh CK, Cho M, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, Choi YY. Clinical Implications of Microsatellite Instability in Early Gastric Cancer. J Gastric Cancer 2019;19:427-37. [PMID: 31897345 DOI: 10.5230/jgc.2019.19.e38] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Liu X, Yang H, Wu X, Huang K, Ma P, Jiang P, Zheng W, Tang T, Liu D. Molecular mutation characteristics of mismatch and homologous recombination repair genes in gastrointestinal cancer. Oncol Lett 2019;18:2789-98. [PMID: 31452757 DOI: 10.3892/ol.2019.10607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 37 |
Negri GL, Grande BM, Delaidelli A, El-Naggar A, Cochrane D, Lau CC, Triche TJ, Moore RA, Jones SJ, Montpetit A, Marra MA, Malkin D, Morin RD, Sorensen PH. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma. J Pathol 2019;249:319-31. [PMID: 31236944 DOI: 10.1002/path.5319] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 38 |
Ciardiello D, Vitiello PP, Cardone C, Martini G, Troiani T, Martinelli E, Ciardiello F. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy. Cancer Treatment Reviews 2019;76:22-32. [DOI: 10.1016/j.ctrv.2019.04.003] [Cited by in Crossref: 149] [Cited by in F6Publishing: 156] [Article Influence: 37.3] [Reference Citation Analysis]
|
| 39 |
Tian W, Bi R, Ren Y, He H, Shi S, Shan B, Yang W, Wang Q, Wang H. Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes. Int J Cancer 2019;145:1290-8. [PMID: 31054147 DOI: 10.1002/ijc.32389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 40 |
Gupta D, Heinen CD. The mismatch repair-dependent DNA damage response: Mechanisms and implications. DNA Repair (Amst) 2019;78:60-9. [PMID: 30959407 DOI: 10.1016/j.dnarep.2019.03.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 41 |
Svrcek M, Lascols O, Cohen R, Collura A, Jonchère V, Fléjou JF, Buhard O, Duval A. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors. Bull Cancer 2019;106:119-28. [PMID: 30713006 DOI: 10.1016/j.bulcan.2018.12.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 42 |
Takeshima H, Yamada H, Ushijima T. Cancer Epigenetics. Oncogenomics. Elsevier; 2019. pp. 65-76. [DOI: 10.1016/b978-0-12-811785-9.00005-3] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Weksberg R, Butcher DT, Cytrynbaum C, Siu MT, Choufani S, Tycko B. Epigenetics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2019. [DOI: 10.1016/b978-0-12-812537-3.00005-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 44 |
Svrcek M, Borralho Nunes P, Villanacci V, Beaugerie L, Rogler G, De Hertogh G, Tripathi M, Feakins R; H-ECCO group. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation. J Crohns Colitis 2018;12:1486-98. [PMID: 30202940 DOI: 10.1093/ecco-jcc/jjy132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 45 |
Lupinacci RM, Bachet JB, André T, Duval A, Svrcek M. Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine. Surg Oncol 2019;28:121-7. [PMID: 30851885 DOI: 10.1016/j.suronc.2018.11.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 46 |
Wong H, Christie M, Gately L, Tie J, Lee B, Semira C, Lok SW, Wong R, Gibbs P. Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond. Future Oncology 2018;14:2725-39. [DOI: 10.2217/fon-2018-0319] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 47 |
Nebot-Bral L, Coutzac C, Kannouche PL, Chaput N. Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors? Bull Cancer 2019;106:105-13. [PMID: 30342749 DOI: 10.1016/j.bulcan.2018.08.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 48 |
Arulananda S, Thapa B, Walkiewicz M, Zapparoli GV, Williams DS, Dobrovic A, John T. Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma. J Thorac Oncol 2018;13:1588-94. [PMID: 30056163 DOI: 10.1016/j.jtho.2018.07.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 49 |
Augustus GJ, Roe DJ, Jacobs ET, Lance P, Ellis NA. Is increased colorectal screening effective in preventing distant disease? PLoS One 2018;13:e0200462. [PMID: 30001362 DOI: 10.1371/journal.pone.0200462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 50 |
Hatakeyama K, Ohshima K, Nagashima T, Ohnami S, Ohnami S, Serizawa M, Shimoda Y, Maruyama K, Akiyama Y, Urakami K, Kusuhara M, Mochizuki T, Yamaguchi K. Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. Sci Rep 2018;8:8700. [PMID: 29880869 DOI: 10.1038/s41598-018-26967-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 51 |
Briffa R, Langdon SP, Grech G, Harrison DJ. Acquired and Intrinsic Resistance to Colorectal Cancer Treatment. Colorectal Cancer - Diagnosis, Screening and Management 2018. [DOI: 10.5772/intechopen.70781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Chen L, Pan X, Hu X, Zhang YH, Wang S, Huang T, Cai YD. Gene expression differences among different MSI statuses in colorectal cancer. Int J Cancer 2018;143:1731-40. [PMID: 29696646 DOI: 10.1002/ijc.31554] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 53 |
Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 54 |
Tam BE, Hao Y, Sikes HD. An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 2018;34:1589-95. [PMID: 29693329 DOI: 10.1002/btpr.2644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 55 |
Jindal V. Immune checkpoint inhibitors in gastrointestinal malignancies. J Gastrointest Oncol 2018;9:390-403. [PMID: 29755779 DOI: 10.21037/jgo.2018.01.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 56 |
Tan SC. Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition. J Gene Med 2018;20:e3010. [PMID: 29424105 DOI: 10.1002/jgm.3010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 57 |
Lupinacci RM, Goloudina A, Buhard O, Bachet JB, Maréchal R, Demetter P, Cros J, Bardier-Dupas A, Collura A, Cervera P, Scriva A, Dumont S, Hammel P, Sauvanet A, Louvet C, Delpéro JR, Paye F, Vaillant JC, André T, Closset J, Emile JF, Van Laethem JL, Jonchère V, Abd Alsamad I, Antoine M, Rodenas A, Fléjou JF, Dusetti N, Iovanna J, Duval A, Svrcek M. Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Gastroenterology 2018;154:1061-5. [PMID: 29158190 DOI: 10.1053/j.gastro.2017.11.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 58 |
Chaabane W, Appell ML. Interconnections between apoptotic and autophagic pathways during thiopurine-induced toxicity in cancer cells: the role of reactive oxygen species. Oncotarget 2016;7:75616-34. [PMID: 27689330 DOI: 10.18632/oncotarget.12313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 59 |
Kosinski L, George B, Turaga KK, Johnstone CA, Mahmoud M. Colon and Rectal Cancer. The American Cancer Society's Oncology in Practice 2018. [DOI: 10.1002/9781118592168.ch9] [Reference Citation Analysis]
|
| 60 |
Chang SY, Kuo CC, Wu CC, Hsiao CW, Hu JM, Hsu CH, Chou YC, Shih YL, Lin YW. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy. Genes Chromosomes Cancer 2018;57:268-77. [PMID: 29363224 DOI: 10.1002/gcc.22529] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 61 |
Islam F, Gopalan V, Pillai S, Lu CT, Kasem K, Lam AK. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer 2018;57:240-51. [PMID: 29318692 DOI: 10.1002/gcc.22525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 62 |
Geng X, Wang F, Zhang L, Zhang WM. Loss of Heterozygosity Combined with Promoter Hypermethylation, the Main Mechanism of Human MutL Homolog (hMLH1) Gene Inactivation in Non-Small Cell Lung Cancer in a Chinese Population. Tumori 2009;95:488-94. [DOI: 10.1177/030089160909500414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 63 |
Hashmi AA, Hashmi SK, Ali N, Thara K, Ali R, Edhi MM, Faridi N, Khan A. Clinicopathologic features of colorectal carcinoma: features predicting higher T-stage and nodal metastasis. BMC Res Notes 2018;11:52. [PMID: 29351808 DOI: 10.1186/s13104-018-3183-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 64 |
Gao D, Herman JG, Guo M. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer. Oncotarget 2016;7:37331-46. [PMID: 26967246 DOI: 10.18632/oncotarget.7949] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 65 |
Matos P, Jordan P. Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability. Adv Exp Med Biol 2018;1110:7-21. [PMID: 30623363 DOI: 10.1007/978-3-030-02771-1_2] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Clarke CN, Scott Kopetz E. Molecular Markers and Mutational Analysis. Rectal Cancer 2018. [DOI: 10.1007/978-3-319-16384-0_19] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 67 |
Katona BW, Lynch JP. Mechanisms of Gastrointestinal Malignancies. Physiology of the Gastrointestinal Tract 2018. [DOI: 10.1016/b978-0-12-809954-4.00066-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 68 |
Tse JWT, Jenkins LJ, Chionh F, Mariadason JM. Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? Trends Cancer. 2017;3:698-712. [PMID: 28958388 DOI: 10.1016/j.trecan.2017.08.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 69 |
Nebot-Bral L, Brandao D, Verlingue L, Rouleau E, Caron O, Despras E, El-Dakdouki Y, Champiat S, Aoufouchi S, Leary A, Marabelle A, Malka D, Chaput N, Kannouche PL. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine. Eur J Cancer 2017;84:290-303. [PMID: 28846956 DOI: 10.1016/j.ejca.2017.07.026] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 70 |
Kim JG, Shin S, Park J. Comparison between mononucleotide and dinucleotide marker panels in gastric cancer with loss of hMLH1 or hMSH2 expression. Int J Biol Markers 2017;32:e352-6. [PMID: 28525661 DOI: 10.5301/ijbm.5000266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 71 |
Park J, Yoo HM, Jang W, Shin S, Kim M, Kim Y, Lee SW, Kim JG. Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer. Medicine (Baltimore) 2017;96:e7224. [PMID: 28640116 DOI: 10.1097/MD.0000000000007224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 72 |
Hashmi AA, Ali R, Hussain ZF, Faridi N, Khan EY, Bakar SMA, Edhi MM, Khan M. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters. World J Surg Oncol 2017;15:116. [PMID: 28651545 DOI: 10.1186/s12957-017-1158-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 73 |
Passardi A, Canale M, Valgiusti M, Ulivi P. Immune Checkpoints as a Target for Colorectal Cancer Treatment. Int J Mol Sci. 2017;18:1324. [PMID: 28635639 DOI: 10.3390/ijms18061324] [Cited by in Crossref: 74] [Cited by in F6Publishing: 88] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 74 |
Perencevich M, Inra J, Syngal S. Colon Cancer Screening. Biomarkers in Cancer Screening and Early Detection 2017. [DOI: 10.1002/9781118468869.ch24] [Reference Citation Analysis]
|
| 75 |
Takamochi K, Takahashi F, Suehara Y, Sato E, Kohsaka S, Hayashi T, Kitano S, Uneno T, Kojima S, Takeuchi K, Mano H, Suzuki K. DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel. Lung Cancer 2017;110:26-31. [PMID: 28676214 DOI: 10.1016/j.lungcan.2017.05.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 76 |
Ryan E, Sheahan K, Creavin B, Mohan HM, Winter DC. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing. Crit Rev Oncol Hematol. 2017;116:38-57. [PMID: 28693799 DOI: 10.1016/j.critrevonc.2017.05.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 77 |
Choi YY, Cheong JH. Beyond precision surgery: Molecularly motivated precision care for gastric cancer. Eur J Surg Oncol 2017;43:856-64. [PMID: 28330821 DOI: 10.1016/j.ejso.2017.02.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 78 |
Carethers JM. Microsatellite Instability Pathway and EMAST in Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13:73-80. [PMID: 28367107 DOI: 10.1007/s11888-017-0352-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 79 |
Li GM. A Personal Tribute to 2015 Nobel Laureate Paul Modrich. DNA Repair (Amst) 2016;37:A14-21. [PMID: 26861181 DOI: 10.1016/j.dnarep.2015.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 80 |
Bupathi M, Wu C. Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others. J Gastrointest Oncol 2016;7:713-20. [PMID: 27747085 DOI: 10.21037/jgo.2016.07.03] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 81 |
Tarn BE, Sung KJ, Sikes HD. Engineering affinity agents for the detection of hemi-methylated CpG sites in DNA. Mol Syst Des Eng 2016;1:273-7. [PMID: 28580176 DOI: 10.1039/C6ME00073H] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 82 |
Baylin SB, Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol 2016;8:a019505. [PMID: 27194046 DOI: 10.1101/cshperspect.a019505] [Cited by in Crossref: 545] [Cited by in F6Publishing: 594] [Article Influence: 77.9] [Reference Citation Analysis]
|
| 83 |
Matos P, Gonçalves V, Jordan P. Targeting the serrated pathway of colorectal cancer with mutation in BRAF. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016;1866:51-63. [DOI: 10.1016/j.bbcan.2016.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 84 |
Modrich P. Mechanismen der Fehlpaarungsreparatur inE. coliund im Menschen (Nobel-Aufsatz). Angew Chem 2016;128:8630-8642. [DOI: 10.1002/ange.201601412] [Reference Citation Analysis]
|
| 85 |
Quiroga D, Lyerly HK, Morse MA. Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer. Curr Treat Options in Oncol 2016;17. [DOI: 10.1007/s11864-016-0414-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 86 |
Kenyon J, Nickel-Meester G, Qing Y, Santos-Guasch G, Drake E, PingfuFu, Sun S, Bai X, Wald D, Arts E, Gerson SL. Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing. Int J Stem Cell Res Ther 2016;3:031. [PMID: 27570841 DOI: 10.23937/2469-570x/1410031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 87 |
Modrich P. Mechanisms in E. coli and Human Mismatch Repair (Nobel Lecture). Angew Chem Int Ed Engl 2016;55:8490-501. [PMID: 27198632 DOI: 10.1002/anie.201601412] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 88 |
Heimer BW, Tam BE, Minkovsky A, Sikes HD. Using nanobiotechnology to increase the prevalence of epigenotyping assays in precision medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017;9. [PMID: 27126368 DOI: 10.1002/wnan.1407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 89 |
Nieminen TT, Niskakoski A, Peltomäki P. Epigenetic Mechanisms in Lynch Syndrome. eLS 2016. [DOI: 10.1002/9780470015902.a0026560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 90 |
Westdorp H, Fennemann FL, Weren RD, Bisseling TM, Ligtenberg MJ, Figdor CG, Schreibelt G, Hoogerbrugge N, Wimmers F, de Vries IJ. Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol Immunother 2016;65:1249-59. [PMID: 27060000 DOI: 10.1007/s00262-016-1832-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 91 |
Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med 2016;14:21. [PMID: 26801617 DOI: 10.1186/s12967-016-0772-5] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 92 |
Sepulveda AR, Ma D, Behling KC, Fernandes H. Colorectal Cancer. Molecular Pathology in Clinical Practice 2016. [DOI: 10.1007/978-3-319-19674-9_31] [Reference Citation Analysis]
|
| 93 |
Chaudhari NT, Tupkari JV, Joy T, Ahire MS. Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population. J Oral Maxillofac Pathol 2016;20:453-61. [PMID: 27721611 DOI: 10.4103/0973-029X.190948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 94 |
Neidhart M. DNA Methylation and Cancer. DNA Methylation and Complex Human Disease. Elsevier; 2016. pp. 103-34. [DOI: 10.1016/b978-0-12-420194-1.00007-5] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 95 |
Dasari A, Choi J, Berdis A. Chemotherapeutic intervention by inhibiting DNA polymerases. DNA Repair in Cancer Therapy 2016. [DOI: 10.1016/b978-0-12-803582-5.00007-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 96 |
Clarke CN, Kopetz ES. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. J Gastrointest Oncol. 2015;6:660-667. [PMID: 26697199 DOI: 10.3978/j.issn.2078-6891.2015.077] [Cited by in F6Publishing: 71] [Reference Citation Analysis]
|
| 97 |
Margalit O, Dubois RN. Neoplasia of the Gastrointestinal Tract. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch31] [Reference Citation Analysis]
|
| 98 |
Joly MO, Attignon V, Saurin JC, Desseigne F, Leroux D, Martin-Denavit T, Giraud S, Bonnet-Dupeyron MN, Faivre L, Auclair J, Grand-Masson C, Audoynaud C, Wang Q. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients. Hum Mutat 2015;36:292-5. [PMID: 25504677 DOI: 10.1002/humu.22740] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 99 |
Kim HJ, Kim N, Choi YJ, Yoon H, Shin CM, Park YS, Lee HS, Ahn SH, Park do J, Kim HH, Son IT, Kang SB, Lee DH. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Gastric Cancer 2016;19:798-807. [PMID: 26445944 DOI: 10.1007/s10120-015-0552-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 100 |
Carethers JM, Jung BH. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. Gastroenterology 2015;149:1177-1190.e3. [PMID: 26216840 DOI: 10.1053/j.gastro.2015.06.047] [Cited by in Crossref: 245] [Cited by in F6Publishing: 276] [Article Influence: 30.6] [Reference Citation Analysis]
|
| 101 |
Hitchins MP. Constitutional epimutation as a mechanism for cancer causality and heritability? Nat Rev Cancer 2015;15:625-34. [PMID: 26383139 DOI: 10.1038/nrc4001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 102 |
Henriques AF, Barros P, Moyer MP, Matos P, Jordan P. Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells. Cancer Lett 2015;369:368-75. [PMID: 26341689 DOI: 10.1016/j.canlet.2015.08.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 103 |
Huang MN, McPherson JR, Cutcutache I, Teh BT, Tan P, Rozen SG. MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations. Sci Rep 2015;5:13321. [PMID: 26306458 DOI: 10.1038/srep13321] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 104 |
Carethers JM, Stoffel EM. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World J Gastroenterol 2015; 21(31): 9253-9261 [PMID: 26309352 DOI: 10.3748/wjg.v21.i31.9253] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 128] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 105 |
Valo S, Kaur S, Ristimäki A, Renkonen-Sinisalo L, Järvinen H, Mecklin JP, Nyström M, Peltomäki P. DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas. Clin Epigenetics 2015;7:71. [PMID: 26203307 DOI: 10.1186/s13148-015-0102-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 106 |
Lynch HT, Drescher K, Knezetic J, Lanspa S. Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review. Curr Treat Options Oncol. 2014;15:429-442. [PMID: 24827900 DOI: 10.1007/s11864-014-0293-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 107 |
Xu W, Xu J, Shestopaloff K, Dicks E, Green J, Parfrey P, Green R, Savas S. A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes. Biomark Res 2015;3:6. [PMID: 25866641 DOI: 10.1186/s40364-015-0031-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 108 |
Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer. 2015;15:181-194. [PMID: 25673086 DOI: 10.1038/nrc3878] [Cited by in Crossref: 444] [Cited by in F6Publishing: 465] [Article Influence: 55.5] [Reference Citation Analysis]
|
| 109 |
Scott A, Wang ZJ. Colon cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.025] [Reference Citation Analysis]
|
| 110 |
Current state of the evolving MMMN cancer progression models of cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.022] [Reference Citation Analysis]
|
| 111 |
Veganzones S, Maestro ML, Rafael S, de la Orden V, Vidaurreta M, Mediero B, Espantaleón M, Cerdán J, Díaz-rubio E. Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors. Tumor Biol 2015;36:3853-61. [DOI: 10.1007/s13277-014-3027-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 112 |
Prasad MA, Jung B. Microsatellite Instability and Intestinal Tumorigenesis. Intestinal Tumorigenesis 2015. [DOI: 10.1007/978-3-319-19986-3_2] [Reference Citation Analysis]
|
| 113 |
Miyakura Y, Tahara M, Lefor AT, Yasuda Y, Sugano K. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers. BMC Res Notes. 2014;7:835. [PMID: 25421847 DOI: 10.1186/1756-0500-7-835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 114 |
Asokan GS, Jeelani S, Gnanasundaram N. Promoter hypermethylation profile of tumour suppressor genes in oral leukoplakia and oral squamous cell carcinoma. J Clin Diagn Res 2014;8:ZC09-12. [PMID: 25478438 DOI: 10.7860/JCDR/2014/9251.4949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 115 |
Geurts-Giele WR, Leenen CH, Dubbink HJ, Meijssen IC, Post E, Sleddens HF, Kuipers EJ, Goverde A, van den Ouweland AM, van Lier MG. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. J Pathol. 2014;234:548-559. [PMID: 25111426 DOI: 10.1002/path.4419] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 116 |
Fang M, Ou J, Hutchinson L, Green MR. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype. Mol Cell. 2014;55:904-915. [PMID: 25219500 DOI: 10.1016/j.molcel.2014.08.010] [Cited by in Crossref: 146] [Cited by in F6Publishing: 126] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 117 |
Tie J, Desai J. Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies. Target Oncol. 2015;10:179-188. [PMID: 25119972 DOI: 10.1007/s11523-014-0330-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 118 |
Leong KJ, Beggs A, James J, Morton DG, Matthews GM, Bach SP. Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation. Br J Surg 2014;101:1299-309. [PMID: 25052224 DOI: 10.1002/bjs.9571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 119 |
Al-Kaabi A, van Bockel LW, Pothen AJ, Willems SM. p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review. Dis Markers 2014;2014:260549. [PMID: 24803719 DOI: 10.1155/2014/260549] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 120 |
Roy DM, Walsh LA, Chan TA. Driver mutations of cancer epigenomes. Protein Cell 2014;5:265-96. [PMID: 24622842 DOI: 10.1007/s13238-014-0031-6] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 121 |
Carethers JM. Differentiating Lynch-like from Lynch syndrome. Gastroenterology 2014;146:602-4. [PMID: 24468183 DOI: 10.1053/j.gastro.2014.01.041] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 122 |
Ziadi S, Ksiaa F, Gacem RB, Labaied N, Mokni M, Trimeche M. Clinicopathologic characteristics of colorectal cancer with microsatellite instability. Pathology - Research and Practice 2014;210:98-104. [DOI: 10.1016/j.prp.2013.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 123 |
Kim TM, Laird PW, Park PJ. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell. 2013;155:858-868. [PMID: 24209623 DOI: 10.1016/j.cell.2013.10.015] [Cited by in Crossref: 257] [Cited by in F6Publishing: 265] [Article Influence: 28.6] [Reference Citation Analysis]
|
| 124 |
Luo Y, Yu M, Grady WM. Field cancerization in the colon: a role for aberrant DNA methylation? Gastroenterol Rep (Oxf). 2014;2:16-20. [PMID: 24760232 DOI: 10.1093/gastro/got039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 125 |
Fix D, Twaddell WS. Molecular Predictive and Prognostic Markers of Colorectal Carcinoma. Pathology Case Reviews 2014;19:252-255. [DOI: 10.1097/pcr.0000000000000057] [Reference Citation Analysis]
|
| 126 |
Gaston D, Giacomantonio C. Genomics of Colorectal Cancer. Cancer Genomics 2014. [DOI: 10.1016/b978-0-12-396967-5.00015-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 127 |
Malhotra P, Anwar M, Kochhar R, Ahmad S, Vaiphei K, Mahmood S. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India. Tumour Biol. 2014;35:3679-3687. [PMID: 24317816 DOI: 10.1007/s13277-013-1487-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 128 |
Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessey E, Sheehan M, Kerin MJ. Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol. 2013;4:397-408. [PMID: 24294512 DOI: 10.3978/j.issn.2078-6891.2013.021] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
|
| 129 |
McPherson LA, Shen Y, Ford JM. Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells. Cancer Lett. 2014;343:217-223. [PMID: 24215868 DOI: 10.1016/j.canlet.2013.10.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 130 |
Rawluszko AA, Bujnicka KE, Horbacka K, Krokowicz P, Jagodziński PP. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer. BMC Cancer 2013;13:526. [PMID: 24195777 DOI: 10.1186/1471-2407-13-526] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 131 |
Kim TM, Lee SH, Chung YJ. Clinical applications of next-generation sequencing in colorectal cancers. World J Gastroenterol 2013; 19(40): 6784-6793 [PMID: 24187453 DOI: 10.3748/wjg.v19.i40.6784] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 132 |
Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci. 2013;14:16365-16385. [PMID: 23965959 DOI: 10.3390/ijms140816365] [Cited by in Crossref: 279] [Cited by in F6Publishing: 305] [Article Influence: 27.9] [Reference Citation Analysis]
|
| 133 |
Ibragimova I, Maradeo ME, Dulaimi E, Cairns P. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC. Epigenetics 2013;8:486-93. [PMID: 23644518 DOI: 10.4161/epi.24552] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 134 |
Yang Z, Huo L, Chen H, Ni B, Xiang J, Kang L, Wang L, Peng J, Yuan Y, Wang J. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Med Oncol 2013;30:586. [PMID: 23609194 DOI: 10.1007/s12032-013-0586-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 135 |
Svrcek M, Fontugne J, Duval A, Fléjou JF. Inflammatory bowel disease-associated colorectal cancers and microsatellite instability: an original relationship. Am J Surg Pathol. 2013;37:460-462. [PMID: 23388128 DOI: 10.1097/PAS.0b013e31827ae150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 33] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 136 |
Edelbrock MA, Kaliyaperumal S, Williams KJ. Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. Mutat Res 2013;743-744:53-66. [PMID: 23391514 DOI: 10.1016/j.mrfmmm.2012.12.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 137 |
Sproul D, Meehan RR. Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics 2013;12:174-90. [PMID: 23341493 DOI: 10.1093/bfgp/els063] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 138 |
Wen YH, Brogi E, Zeng Z, Akram M, Catalano J, Paty PB, Norton L, Shia J. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors. Am J Surg Pathol 2012;36:1700-8. [PMID: 22992699 DOI: 10.1097/PAS.0b013e3182627787] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 139 |
Svrcek M, El-Murr N, Wanherdrick K, Dumont S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF, Lesuffleur T. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. Carcinogenesis. 2013;34:828-834. [PMID: 23288924 DOI: 10.1093/carcin/bgs408] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 140 |
Boland CR, Jung B, Carethers JM. Cancer of the Colon and Gastrointestinal Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00074-4] [Reference Citation Analysis]
|
| 141 |
Roper J, Hung KE. Molecular Mechanisms of Colorectal Carcinogenesis. Molecular Pathogenesis of Colorectal Cancer 2013. [DOI: 10.1007/978-1-4614-8412-7_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 142 |
Sohal D, Sepulveda AR, Sun W. Targeted Therapies and Molecular Diagnostics of Gastrointestinal Cancers. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_2] [Reference Citation Analysis]
|
| 143 |
Rashid A. Molecular Pathology of Colon and Small Bowel Cancers: Sporadic Type. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_8] [Reference Citation Analysis]
|
| 144 |
Francipane MG, Lagasse E. A Study of Cancer Heterogeneity: From Genetic Instability to Epigenetic Diversity in Colorectal Cancer. Cancer Targeted Drug Delivery 2013. [DOI: 10.1007/978-1-4614-7876-8_14] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 145 |
Geng H, Hsieh P. Molecular Mechanisms and Functions of DNA Mismatch Repair. DNA Alterations in Lynch Syndrome 2013. [DOI: 10.1007/978-94-007-6597-9_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 146 |
Weksberg R, Butcher DT, Grafodatskaya D, Choufani S, Tycko B. Epigenetics. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00006-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 147 |
Jenab-wolcott J, Giantonio B. Cancers of the Rectum and Anal Canal. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_9] [Reference Citation Analysis]
|
| 148 |
Scott FI, Lynch JP. Mechanisms of Gastrointestinal Carcinogenesis. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_1] [Reference Citation Analysis]
|
| 149 |
Majid S, Saini S, Deng G, Dahiya R. Epigenetics and MicroRNAs in Renal Cancer. Epigenetics and Cancer 2013. [DOI: 10.1007/978-94-007-6612-9_4] [Reference Citation Analysis]
|
| 150 |
Tseng-Rogenski SS, Chung H, Wilk MB, Zhang S, Iwaizumi M, Carethers JM. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells. PLoS One. 2012;7:e50616. [PMID: 23226332 DOI: 10.1371/journal.pone.0050616] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 151 |
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3:153-173. [PMID: 22943008 DOI: 10.3978/j.issn.2078-6891.2012.030] [Cited by in F6Publishing: 195] [Reference Citation Analysis]
|
| 152 |
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3:153-173. [PMID: 22943008 DOI: 10.3978j/issn.2078-6891.2012.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 153 |
Majumdar S, Buckles E, Estrada J, Koochekpour S. . CG 2011;12:486-505. [DOI: 10.2174/138920211797904061] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 154 |
Abdel-Rahman WM, Ruosaari S, Knuutila S, Peltomäki P. Differential roles of EPS8 in carcinogenesis: Loss of protein expression in a subset of colorectal carcinoma and adenoma. World J Gastroenterol 2012; 18(29): 3896-3903 [PMID: 22876043 DOI: 10.3748/wjg.v18.i29.3896] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 155 |
Luo Y, Tsuchiya KD, Il Park D, Fausel R, Kanngurn S, Welcsh P, Dzieciatkowski S, Wang J, Grady WM. RET is a potential tumor suppressor gene in colorectal cancer. Oncogene. 2013;32:2037-2047. [PMID: 22751117 DOI: 10.1038/onc.2012.225] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 156 |
Kenyon J, Fu P, Lingas K, Thomas E, Saurastri A, Santos Guasch G, Wald D, Gerson SL. Humans accumulate microsatellite instability with acquired loss of MLH1 protein in hematopoietic stem and progenitor cells as a function of age. Blood 2012;120:3229-36. [PMID: 22740444 DOI: 10.1182/blood-2011-12-401950] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 157 |
Hassen S, Ali N, Chowdhury P. Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer. World J Gastrointest Pathophysiol 2012; 3(3): 71-79 [PMID: 22737591 DOI: 10.4291/wjgp.v3.i3.71] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 158 |
Balasubramanian D, Akhtar-Zaidi B, Song L, Bartels CF, Veigl M, Beard L, Myeroff L, Guda K, Lutterbaugh J, Willis J, Crawford GE, Markowitz SD, Scacheri PC. H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites. Genome Med 2012;4:47. [PMID: 22640407 DOI: 10.1186/gm346] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 159 |
Sandhu S, Wu X, Nabi Z, Rastegar M, Kung S, Mai S, Ding H. Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer 2012;11:18. [PMID: 22452792 DOI: 10.1186/1476-4598-11-18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 160 |
de Miranda NFCC, Hes FJ, van Wezel T, Morreau H. Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers. Mutagenesis 2012;27:247-53. [DOI: 10.1093/mutage/ger077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 161 |
Khare S, Verma M. Epigenetics of colon cancer. Methods Mol Biol 2012;863:177-85. [PMID: 22359293 DOI: 10.1007/978-1-61779-612-8_10] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 162 |
Lynch JP, Rustgi AK. Mechanisms of GI Malignancies. Physiology of the Gastrointestinal Tract 2012. [DOI: 10.1016/b978-0-12-382026-6.00080-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 163 |
Li LS, Wagner M, Meyers M, Boothman DA. Defective DNA Mismatch Repair-dependent c-Abl-p73-GADD45α Expression Confers Cancer Chemoresistance. DNA Repair in Cancer Therapy 2012. [DOI: 10.1016/b978-0-12-384999-1.10009-5] [Reference Citation Analysis]
|
| 164 |
Gonzalgo ML, Meeker AK. Molecular Genetics and Cancer Biology. Campbell-Walsh Urology 2012. [DOI: 10.1016/b978-1-4160-6911-9.00018-9] [Reference Citation Analysis]
|
| 165 |
Berdis AJ. Chemotherapeutic Intervention by Inhibiting DNA Polymerases. DNA Repair in Cancer Therapy 2012. [DOI: 10.1016/b978-0-12-384999-1.10005-8] [Reference Citation Analysis]
|
| 166 |
Peltomäki P. Mutations and epimutations in the origin of cancer. Exp Cell Res 2012;318:299-310. [PMID: 22182599 DOI: 10.1016/j.yexcr.2011.12.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 167 |
Aston KI, Carrell DT. Emerging evidence for the role of genomic instability in male factor infertility. Syst Biol Reprod Med 2012;58:71-80. [PMID: 22142145 DOI: 10.3109/19396368.2011.635751] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 168 |
Van Neste L, Jones GR, Van Criekinge W, Clark JS. Epigenetic-based companion diagnostics. Personalized Medicine 2011;8:623-31. [DOI: 10.2217/pme.11.70] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 169 |
Heijink DM, de Vries EG, Koornstra JJ, Hospers GA, Hofstra RM, van Vugt MA, de Jong S, Kleibeuker JH. Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome. Critical Reviews in Oncology/Hematology 2011;80:264-77. [DOI: 10.1016/j.critrevonc.2010.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 170 |
George B, Kopetz S. Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep 2011;13:206-15. [PMID: 21373987 DOI: 10.1007/s11912-011-0162-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 171 |
Alhopuro P, Sammalkorpi H, Niittymäki I, Biström M, Raitila A, Saharinen J, Nousiainen K, Lehtonen HJ, Heliövaara E, Puhakka J, Tuupanen S, Sousa S, Seruca R, Ferreira AM, Hofstra RM, Mecklin JP, Järvinen H, Ristimäki A, Orntoft TF, Hautaniemi S, Arango D, Karhu A, Aaltonen LA. Candidate driver genes in microsatellite-unstable colorectal cancer. Int J Cancer 2012;130:1558-66. [PMID: 21544814 DOI: 10.1002/ijc.26167] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 172 |
Nagata M, Sakurai-yageta M, Yamada D, Goto A, Ito A, Fukuhara H, Kume H, Morikawa T, Fukayama M, Homma Y, Murakami Y. Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma. Int J Cancer 2012;130:1329-37. [DOI: 10.1002/ijc.26160] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 173 |
Pan XM, Yang WZ, Xu GH, Bai P, Qin HJ, Zhang LS, Zhai XD, Tang M, Deng W, Zhang L, Gao LB. The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 2011;26:667-73. [PMID: 21745804 DOI: 10.1093/mutage/ger032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 174 |
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 2011;396:1017-1026. [PMID: 21706233 DOI: 10.1007/s00423-011-0812-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 175 |
Dolinoy DC, Anderson OS, Rozek LS. Epigenetic Manifestation of Environmental Exposures. Nutrition in Epigenetics 2011. [DOI: 10.1002/9780470959824.ch18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 176 |
Tejpar S, Saridaki Z, Delorenzi M, Bosman F, Roth AD. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle. J Natl Cancer Inst. 2011;103:841-844. [PMID: 21597023 DOI: 10.1093/jnci/djr170] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 177 |
Tie J, Gibbs P, Lipton L, Christie M, Jorissen RN, Burgess AW, Croxford M, Jones I, Langland R, Kosmider S, McKay D, Bollag G, Nolop K, Sieber OM, Desai J. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Int J Cancer. 2011;128:2075-2084. [PMID: 20635392 DOI: 10.1002/ijc.25555] [Cited by in Crossref: 160] [Cited by in F6Publishing: 179] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 178 |
Alhosin M, Sharif T, Mousli M, Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB, Bronner C. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res 2011;30:41. [PMID: 21496237 DOI: 10.1186/1756-9966-30-41] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 179 |
Kulendran M, Stebbing JF, Marks CG, Rockall TA. Predictive and prognostic factors in colorectal cancer: a personalized approach. Cancers (Basel). 2011;3:1622-1638. [PMID: 24212777 DOI: 10.3390/cancers3021622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 180 |
Moussa SA, Moussa A, Kourda N, Mezlini A, Abdelli N, Zerimech F, Najjar T, Jilani SB, Porchet N, Ayed FB. Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis. 2011;26:455-467. [PMID: 21311894 DOI: 10.1007/s00384-010-1129-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 181 |
Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol. 2011;18:2338-2347. [PMID: 21298349 DOI: 10.1245/s10434-011-1573-y] [Cited by in Crossref: 111] [Cited by in F6Publishing: 123] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 182 |
Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci. 2011;68:1681-1702. [PMID: 21249513 DOI: 10.1007/s00018-010-0624-z] [Cited by in Crossref: 115] [Cited by in F6Publishing: 103] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 183 |
Svrcek M, Cervera P, Hamelin R, Lascols O, Duval A, Fléjou J. Cancer colorectal : les nouveaux rôles du pathologiste à l’ère de la biologie moléculaire et des thérapies « ciblées ». Revue Francophone des Laboratoires 2011;2011:29-41. [DOI: 10.1016/s1773-035x(11)70859-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 184 |
Michaelson-cohen R, Keshet I, Straussman R, Hecht M, Cedar H, Beller U. Genome-Wide De Novo Methylation in Epithelial Ovarian Cancer. Int J Gynecol Cancer 2011;21:269-79. [DOI: 10.1097/igc.0b013e31820e5cda] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 185 |
Putiri EL, Robertson KD. Epigenetic mechanisms and genome stability. Clin Epigenetics 2011;2:299-314. [PMID: 21927626 DOI: 10.1007/s13148-010-0017-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 186 |
Estécio MR, Issa JP. Dissecting DNA hypermethylation in cancer. FEBS Lett 2011;585:2078-86. [PMID: 21146531 DOI: 10.1016/j.febslet.2010.12.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 187 |
Chung H, Chaudhry J, Lopez CG, Carethers JM. Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner. Cancer Biol Ther 2010;10:1147-56. [PMID: 20930505 DOI: 10.4161/cbt.10.11.13447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 188 |
Svrcek M. [Hereditary gastric cancer: the pathologist's point of view]. Ann Pathol 2010;30:84-7. [PMID: 21055555 DOI: 10.1016/j.annpat.2010.08.005] [Reference Citation Analysis]
|
| 189 |
Scaffidi P, Misteli T. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells. Cold Spring Harb Symp Quant Biol 2010;75:251-8. [PMID: 21047903 DOI: 10.1101/sqb.2010.75.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 190 |
Oyer JA, Yates PA, Godsey S, Turker MS. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation. Mutat Res 2011;706:21-7. [PMID: 21035468 DOI: 10.1016/j.mrfmmm.2010.10.006] [Reference Citation Analysis]
|
| 191 |
Pardo CE, Carr IM, Hoffman CJ, Darst RP, Markham AF, Bonthron DT, Kladde MP. MethylViewer: computational analysis and editing for bisulfite sequencing and methyltransferase accessibility protocol for individual templates (MAPit) projects. Nucleic Acids Res 2011;39:e5. [PMID: 20959287 DOI: 10.1093/nar/gkq716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 192 |
de Maat MF, Narita N, Benard A, Yoshimura T, Kuo C, Tollenaar RA, de Miranda NF, Turner RR, van de Velde CJ, Morreau H, Hoon DS. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. Am J Pathol 2010;177:2347-56. [PMID: 20952593 DOI: 10.2353/ajpath.2010.091103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 193 |
Mrkonjic M, Roslin NM, Greenwood CM, Raptis S, Pollett A, Laird PW, Pethe VV, Chiang T, Daftary D, Dicks E, Thibodeau SN, Gallinger S, Parfrey PS, Younghusband HB, Potter JD, Hudson TJ, McLaughlin JR, Green RC, Zanke BW, Newcomb PA, Paterson AD, Bapat B. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. PLoS One 2010;5:e13314. [PMID: 20967208 DOI: 10.1371/journal.pone.0013314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 194 |
Sabatino MA, Marabese M, Ganzinelli M, Caiola E, Geroni C, Broggini M. Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells. Mol Cancer 2010;9:259. [PMID: 20868484 DOI: 10.1186/1476-4598-9-259] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 195 |
Samuelsson JK, Alonso S, Yamamoto F, Perucho M. DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. Mutat Res 2010;693:61-76. [PMID: 20851135 DOI: 10.1016/j.mrfmmm.2010.08.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 196 |
Huang SC, Lee JK, Smith EJ, Doctolero RT, Tajima A, Beck SE, Weidner N, Carethers JM. Evidence for an hMSH3 defect in familial hamartomatous polyps. Cancer 2011;117:492-500. [PMID: 20845481 DOI: 10.1002/cncr.25445] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 197 |
Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics 2010;5:491-8. [PMID: 20543579 DOI: 10.4161/epi.5.6.12431] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 198 |
Niv Y, Vilkin A, Brenner B, Kendel Y, Morgenstern S, Levi Z. hMLH1 promoter methylation and JC virus T antigen presence in the tumor tissue of colorectal cancer Israeli patients of different ethnic groups. Eur J Gastroenterol Hepatol 2010;22:938-41. [PMID: 20531010 DOI: 10.1097/MEG.0b013e32832e9d2c] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 199 |
Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. World J Gastroenterol 2010; 16(28): 3553-3560 [PMID: 20653064 DOI: 10.3748/wjg.v16.i28.3553] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 200 |
Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, Radosevich JA. Nitric oxide: perspectives and emerging studies of a well known cytotoxin. Int J Mol Sci 2010;11:2715-45. [PMID: 20717533 DOI: 10.3390/ijms11072715] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 201 |
Varley KE, Mitra RD. Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples. Genome Res 2010;20:1279-87. [PMID: 20627893 DOI: 10.1101/gr.101212.109] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 202 |
Drescher KM, Sharma P, Lynch HT. Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients. Clin Dev Immunol 2010;2010:170432. [PMID: 20631828 DOI: 10.1155/2010/170432] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 203 |
Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Soares JM, Castedo S, Carneiro F, Roviello F. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer. 2011;128:1606-1613. [PMID: 20533283 DOI: 10.1002/ijc.25495] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 204 |
Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-2087.e3. [PMID: 20420947 DOI: 10.1053/j.gastro.2009.12.064] [Cited by in Crossref: 1251] [Cited by in F6Publishing: 1350] [Article Influence: 96.2] [Reference Citation Analysis]
|
| 205 |
Ng K, Schrag D. Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol. 2010;28:3207-3210. [PMID: 20498398 DOI: 10.1200/jco.2010.28.9314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 206 |
D'Orazio JA. Inherited cancer syndromes in children and young adults. J Pediatr Hematol Oncol 2010;32:195-228. [PMID: 20186103 DOI: 10.1097/MPH.0b013e3181ced34c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 207 |
Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010;29:181-206. [PMID: 20135198 DOI: 10.1007/s10555-010-9207-6] [Cited by in Crossref: 210] [Cited by in F6Publishing: 227] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 208 |
Kang KJ, Sinn DH, Park SH, Kim JY, Chang DK, Son HJ, Rhee P, Kim JJ, Rhee JC, Chun H, Kim Y. Adenoma incidence after resection of sporadic colorectal cancer with microsatellite instability. J Surg Oncol 2010;101:577-81. [DOI: 10.1002/jso.21548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 209 |
Dronamraju SS, Coxhead JM, Kelly SB, Mathers JC. Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer 2010;62:105-15. [PMID: 20043265 DOI: 10.1080/01635580903191486] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 210 |
Martin SA, Hewish M, Lord CJ, Ashworth A. Genomic instability and the selection of treatments for cancer. J Pathol. 2010;220:281-289. [PMID: 19890832 DOI: 10.1002/path.2631] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 211 |
Jiang Z, Jin S, Yalowich JC, Brown KD, Rajasekaran B. The mismatch repair system modulates curcumin sensitivity through induction of DNA strand breaks and activation of G2-M checkpoint. Mol Cancer Ther 2010;9:558-68. [PMID: 20145018 DOI: 10.1158/1535-7163.MCT-09-0627] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 212 |
Chung H, Lopez CG, Young DJ, Lai JF, Holmstrom J, Ream-Robinson D, Cabrera BL, Carethers JM. Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR). Oncogene 2010;29:2172-80. [PMID: 20140012 DOI: 10.1038/onc.2009.508] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 213 |
Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460. [PMID: 20018966 DOI: 10.1056/NE] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 214 |
Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460. [PMID: 20018966 DOI: 10.1056/nejmra0804588] [Cited by in Crossref: 1216] [Cited by in F6Publishing: 1315] [Article Influence: 93.5] [Reference Citation Analysis]
|
| 215 |
Sepulveda AR, Lynch JP. Genetic Instability and Chronic Inflammation in Gastrointestinal Cancers. Cancer Genome and Tumor Microenvironment 2010. [DOI: 10.1007/978-1-4419-0711-0_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 216 |
Kloor M, von Knebel Doeberitz M, Gebert J. Molekulare Pathogenese, Diagnostik und Therapie hereditärer Tumoren des Gastrointestinaltrakts. Praxis der Viszeralchirurgie Onkologische Chirurgie 2010. [DOI: 10.1007/978-3-642-03808-2_5] [Reference Citation Analysis]
|
| 217 |
Lynch HT, Hitchins MP, Shaw TG, Lynch JF, Roy H. Historical Aspects of Lynch Syndrome. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 218 |
Pal T, Wey JP, Sellers TA. Genetic Epidemiology of Mismatch Repair Deficiency in Ovarian Cancer. Environmental Factors, Genes, and the Development of Human Cancers 2010. [DOI: 10.1007/978-1-4419-6752-7_14] [Reference Citation Analysis]
|
| 219 |
Araki S, Eitel JA, Batuello CN, Bijangi-Vishehsaraei K, Xie XJ, Danielpour D, Pollok KE, Boothman DA, Mayo LD. TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest 2010;120:290-302. [PMID: 19955655 DOI: 10.1172/JCI39194] [Cited by in Crossref: 99] [Cited by in F6Publishing: 106] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 220 |
Blastyák A, Hajdú I, Unk I, Haracska L. Role of double-stranded DNA translocase activity of human HLTF in replication of damaged DNA. Mol Cell Biol 2010;30:684-93. [PMID: 19948885 DOI: 10.1128/MCB.00863-09] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 221 |
van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. J Cell Mol Med 2010;14:181-97. [PMID: 19929944 DOI: 10.1111/j.1582-4934.2009.00977.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 222 |
Hahn MA, Pfeifer GP. Methods for genome-wide analysis of DNA methylation in intestinal tumors. Mutat Res 2010;693:77-83. [PMID: 19854208 DOI: 10.1016/j.mrfmmm.2009.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 223 |
Perrett CM, Harwood CA, McGregor JM, Warwick J, Cerio R, Karran P. Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients. Br J Dermatol 2010;162:732-42. [PMID: 19818066 DOI: 10.1111/j.1365-2133.2009.09550.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 224 |
Li LS, Morales JC, Veigl M, Sedwick D, Greer S, Meyers M, Wagner M, Fishel R, Boothman DA. DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets. Br J Pharmacol 2009;158:679-92. [PMID: 19775280 DOI: 10.1111/j.1476-5381.2009.00423.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 225 |
Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers. Int J Cancer 2009;125:1231-7. [PMID: 19462453 DOI: 10.1002/ijc.24484] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 226 |
Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009;69:7053-7061. [PMID: 19690142 DOI: 10.1158/0008-5472.can-09-0358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 227 |
Li VS, Yuen ST, Chan TL, Yan HH, Law WL, Yeung BH, Chan AS, Tsui WY, So S, Chen X, Leung SY. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Gastroenterology 2009;137:176-87. [PMID: 19303019 DOI: 10.1053/j.gastro.2009.03.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 228 |
Mei M, Deng D, Liu TH, Sang XT, Lu X, Xiang HD, Zhou J, Wu H, Yang Y, Chen J. Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas. J Clin Endocrinol Metab. 2009;94:3448-3457. [PMID: 19567531 DOI: 10.1210/jc.2009-0173] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 229 |
Varley KE, Mutch DG, Edmonston TB, Goodfellow PJ, Mitra RD. Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing. Nucleic Acids Res 2009;37:4603-12. [PMID: 19494183 DOI: 10.1093/nar/gkp457] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 230 |
Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol. 2009;33:691-704. [PMID: 19252434 DOI: 10.1097/pas.0b013e3181983ef7] [Cited by in Crossref: 88] [Cited by in F6Publishing: 97] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 231 |
Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol. 2009;27:1814-1821. [PMID: 19273709 DOI: 10.1200/jco.2008.18.2071] [Cited by in Crossref: 279] [Cited by in F6Publishing: 305] [Article Influence: 19.9] [Reference Citation Analysis]
|
| 232 |
Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, Young J, Jenkins MA, Hopper JL, Baron JA, Buchanan D, Casey G, Levine AJ, Le Marchand L, Gallinger S, Bapat B, Potter JD, Newcomb PA, Haile RW, Laird PW; Colon Cancer Family Registry Investigators. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008;17:3208-15. [PMID: 18990764 DOI: 10.1158/1055-9965.EPI-08-0512] [Cited by in Crossref: 149] [Cited by in F6Publishing: 160] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 233 |
Koutros S, Lynch CF, Ma X, Lee WJ, Hoppin JA, Christensen CH, Andreotti G, Freeman LB, Rusiecki JA, Hou L. Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study. Int J Cancer. 2009;124:1206-1212. [PMID: 19058219 DOI: 10.1002/ijc.24020] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 234 |
Nyström M, Mutanen M. Diet and epigenetics in colon cancer. World J Gastroenterol 2009; 15(3): 257-263 [PMID: 19140224 DOI: 10.3748/wjg.15.257] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 235 |
Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin A, Heslin M, Bellacosa A, Arnoletti JP. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther. 2009;8:94-100. [PMID: 19127118 DOI: 10.4161/cbt.8.1.7469] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 236 |
Marlowe J, Teo SS, Chibout SD, Pognan F, Moggs J. Mapping the epigenome--impact for toxicology. EXS 2009;99:259-88. [PMID: 19157065 DOI: 10.1007/978-3-7643-8336-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 237 |
Lee KY. Genomic Instability in Colorectal Cancer; from Bench to Bed. J Korean Soc Coloproctol 2009;25:129. [DOI: 10.3393/jksc.2009.25.2.129] [Reference Citation Analysis]
|
| 238 |
Baker JC Jr, Ostrander JH, Lem S, Broadwater G, Bean GR, D'Amato NC, Goldenberg VK, Rowell C, Ibarra-Drendall C, Grant T, Pilie PG, Vasilatos SN, Troch MM, Scott V, Wilke LG, Paisie C, Rabiner SM, Torres-Hernandez A, Zalles CM, Seewaldt VL. ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiol Biomarkers Prev 2008;17:1884-90. [PMID: 18708376 DOI: 10.1158/1055-9965.EPI-07-2696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 239 |
Alemayehu A, Sebova K, Fridrichova I. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Genes Chromosomes Cancer 2008;47:906-14. [PMID: 18618713 DOI: 10.1002/gcc.20586] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 240 |
Chung H, Young DJ, Lopez CG, Le TA, Lee JK, Ream-Robinson D, Huang SC, Carethers JM. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair. PLoS One 2008;3:e3463. [PMID: 18941508 DOI: 10.1371/journal.pone.0003463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008;135:1079-99. [PMID: 18773902 DOI: 10.1053/j.gastro.2008.07.076] [Cited by in Crossref: 612] [Cited by in F6Publishing: 670] [Article Influence: 40.8] [Reference Citation Analysis]
|
| 242 |
Biswas S, Trobridge P, Romero-Gallo J, Billheimer D, Myeroff LL, Willson JK, Markowitz SD, Grady WM. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer 2008;47:95-106. [PMID: 17985359 DOI: 10.1002/gcc.20511] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 243 |
Berdis AJ. DNA polymerases as therapeutic targets. Biochemistry 2008;47:8253-60. [PMID: 18642851 DOI: 10.1021/bi801179f] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 244 |
Graham T, Halford S, Page KM, Tomlinson IP. Most low-level microsatellite instability in colorectal cancers can be explained without an elevated slippage rate. J Pathol 2008;215:204-10. [PMID: 18442191 DOI: 10.1002/path.2351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 245 |
Müller CI, Schulmann K, Reinacher-Schick A, Andre N, Arnold D, Tannapfel A, Arkenau H, Hahn SA, Schmoll SH, Porschen R, Schmiegel W, Graeven U; AIO Colorectal Study Group. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group. Int J Colorectal Dis 2008;23:1033-9. [PMID: 18594845 DOI: 10.1007/s00384-008-0504-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 246 |
Sengupta N, Gill KA, MacFie TS, Lai CS, Suraweera N, Mcdonald S, Silver A. Management of colorectal cancer: a role for genetics in prevention and treatment? Pathol Res Pract 2008;204:469-77. [PMID: 18534770 DOI: 10.1016/j.prp.2008.03.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 247 |
Wagner MW, Li LS, Morales JC, Galindo CL, Garner HR, Bornmann WG, Boothman DA. Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses. J Biol Chem 2008;283:21382-93. [PMID: 18480061 DOI: 10.1074/jbc.M709953200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 248 |
Wu AC, Liu XS, Yang K. Relationship between mismatch repair gene hMLH1 promoter methylation and gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(13): 1407-1411 [DOI: 10.11569/wcjd.v16.i13.1407] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 249 |
Odin E, Wettergren Y, Nilsson S, Carlsson G, Gustavsson B. Colorectal carcinomas with microsatellite instability display increased thymidylate synthase gene expression levels. Clin Colorectal Cancer. 2007;6:720-727. [PMID: 18039426 DOI: 10.3816/ccc.2007.n.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 250 |
Harley I, Rosen B, Risch HA, Siminovitch K, Beiner ME, McLaughlin J, Sun P, Narod SA. Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1. Gynecol Oncol 2008;109:384-7. [PMID: 18405947 DOI: 10.1016/j.ygyno.2007.11.046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 251 |
Yauk CL, Polyzos A, Rowan-Carroll A, Kortubash I, Williams A, Kovalchuk O. Tandem repeat mutation, global DNA methylation, and regulation of DNA methyltransferases in cultured mouse embryonic fibroblast cells chronically exposed to chemicals with different modes of action. Environ Mol Mutagen 2008;49:26-35. [PMID: 18172875 DOI: 10.1002/em.20359] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 252 |
Hakem R. DNA-damage repair; the good, the bad, and the ugly. EMBO J. 2008;27:589-605. [PMID: 18285820 DOI: 10.1038/emboj.2008.15] [Cited by in Crossref: 319] [Cited by in F6Publishing: 330] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 253 |
Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18:85-98. [PMID: 18157157 DOI: 10.1038/cr.2007.115] [Cited by in Crossref: 816] [Cited by in F6Publishing: 872] [Article Influence: 54.4] [Reference Citation Analysis]
|
| 254 |
Carethers JM, Chung H, Tajima A. Mismatch repair competency predicts 5-fluorouracil effectiveness on patient survival. Falk Symposium. [DOI: 10.1007/978-1-4020-6826-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 255 |
Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, Tanaka T, Nagawa H. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. J Surg Oncol. 2007;96:611-618. [PMID: 17786961 DOI: 10.1002/jso.20877] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 256 |
Gallmeier E, Kern SE. Genetic Pathways in Pancreatic Tumorigenesis. Diseases of the Pancreas. [DOI: 10.1007/978-3-540-28656-1_52] [Reference Citation Analysis]
|
| 257 |
Abdel-Rahman WM, Knuutila S, Peltomäki P, Harrison DJ, Bader SA. Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells. DNA Repair (Amst) 2008;7:321-8. [PMID: 18162445 DOI: 10.1016/j.dnarep.2007.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 258 |
Vladimirova V, Denkhaus D, Soerensen N, Wagner S, Wolff JE, Pietsch T. Low level of microsatellite instability in paediatric malignant astrocytomas. Neuropathol Appl Neurobiol 2008;34:547-54. [PMID: 18053027 DOI: 10.1111/j.1365-2990.2007.00919.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 259 |
Narayan S. Colorectal Cancer. Principles of Molecular Medicine. [DOI: 10.1007/978-1-59259-963-9_73] [Reference Citation Analysis]
|
| 260 |
Grady WM. Molecular Biology of Colon Cancer. Current Clinical Oncology. [DOI: 10.1007/978-1-59745-215-1_1] [Reference Citation Analysis]
|
| 261 |
Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. J Clin Oncol. 2007;25:4231-4238. [PMID: 17878476 DOI: 10.1200/jco.2007.10.9744] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 262 |
Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer 2007;6:53-62. [PMID: 17039269 DOI: 10.1007/s10689-006-9104-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 263 |
Kim YS, Deng G. Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. Gut Liver 2007;1:1-11. [PMID: 20485652 DOI: 10.5009/gnl.2007.1.1.1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 264 |
Eckert A, Kloor M, Giersch A, Ahmadi R, Herold-Mende C, Hampl JA, Heppner FL, Zoubaa S, Holinski-Feder E, Pietsch T, Wiestler OD, von Knebel Doeberitz M, Roth W, Gebert J. Microsatellite instability in pediatric and adult high-grade gliomas. Brain Pathol 2007;17:146-50. [PMID: 17388945 DOI: 10.1111/j.1750-3639.2007.00049.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 265 |
Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-440. [PMID: 17522677 DOI: 10.1038/nature05919] [Cited by in Crossref: 1195] [Cited by in F6Publishing: 1254] [Article Influence: 74.7] [Reference Citation Analysis]
|
| 266 |
Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43:1348-1360. [PMID: 17512720 DOI: 10.1016/j.ejca.2007.03.021] [Cited by in Crossref: 321] [Cited by in F6Publishing: 342] [Article Influence: 20.1] [Reference Citation Analysis]
|
| 267 |
Kaz A, Kim YH, Dzieciatkowski S, Lynch H, Watson P, Kay Washington M, Lin L, Grady WM. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer 2007;120:1922-9. [PMID: 17278092 DOI: 10.1002/ijc.22544] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 268 |
Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, Schmidt AP, Feng S, Hampel HL, de la Chapelle A, Goodfellow PJ. Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer. 2007;120:1684-1688. [PMID: 17230510 DOI: 10.1002/ijc.22406] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 269 |
Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS. MLH1 -93G& gt; A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst. 2007;99:463-474. [PMID: 17374836 DOI: 10.1093/jnci/djk095] [Cited by in Crossref: 95] [Cited by in F6Publishing: 108] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 270 |
Tronov VA, Kramarenko II, Zakharov SF. Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR. Russ J Genet 2007;43:430-436. [DOI: 10.1134/s1022795407040126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 271 |
Niv Y. Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer. World J Gastroenterol 2007; 13(12): 1767-1769 [PMID: 17465465 DOI: 10.3748/wjg.v13.i12.1767] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 272 |
Grady WM, Ulrich CM. DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? Gut 2007;56:318-20. [PMID: 17339242 DOI: 10.1136/gut.2006.106849] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 273 |
Jo WS, Carethers JM. Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark 2006;2:51-60. [PMID: 17192059 DOI: 10.3233/cbm-2006-21-206] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 274 |
Ollikainen M, Hannelius U, Lindgren CM, Abdel-Rahman WM, Kere J, Peltomäki P. Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach. Oncogene 2007;26:4541-9. [PMID: 17260015 DOI: 10.1038/sj.onc.1210236] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 275 |
Kloor M, von Knebel Doeberitz M, Gebert JF. Molecular testing for microsatellite instability and its value in tumor characterization. Expert Rev Mol Diagn 2005;5:599-611. [PMID: 16013977 DOI: 10.1586/14737159.5.4.599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 276 |
Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007;25:781-6. [PMID: 17228022 DOI: 10.1200/JCO.2006.06.9781] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 277 |
Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007;56:140-8. [PMID: 16840508 DOI: 10.1136/gut.2005.088799] [Cited by in Crossref: 124] [Cited by in F6Publishing: 128] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 278 |
Kobayashi K, Karran P, Oda S, Yanaga K. Involvement of mismatch repair in transcription-coupled nucleotide excision repair. Hum Cell 2005;18:103-15. [PMID: 17022143 DOI: 10.1111/j.1749-0774.2005.tb00001.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 279 |
Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y. Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells. Oncogene 2007;26:2873-84. [PMID: 17086209 DOI: 10.1038/sj.onc.1210098] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 280 |
Jascur T, Boland CR. Structure and function of the components of the human DNA mismatch repair system. Int J Cancer. 2006;119:2030-2035. [PMID: 16804905 DOI: 10.1002/ijc.22023] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 281 |
Tuupanen S, Karhu A, Järvinen H, Mecklin JP, Launonen V, Aaltonen LA. No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer. Oncogene 2007;26:2513-7. [DOI: 10.1038/sj.onc.1210038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 282 |
Snover DC. Serrated polyps of the large intestine. Semin Diagn Pathol. 2005;22:301-308. [PMID: 16939058 DOI: 10.1053/j.semdp.2006.04.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 283 |
Kim YH, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD, Grady WM. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006;45:781-9. [PMID: 16708352 DOI: 10.1002/gcc.20341] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 284 |
Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR. Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 2006;8:305-11. [PMID: 16825502 DOI: 10.2353/jmoldx.2006.050092] [Cited by in Crossref: 191] [Cited by in F6Publishing: 209] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 285 |
Oliart S, Martínez-santos C, Moreno-azcoita M, Cerquella C, Nejda N, Daimiel L, Iglesias D, Fernández-peralta AM, González-aguilera JJ. Do MSI-L Sporadic Colorectal Tumors Develop Through “Mild Mutator Pathway”? American Journal of Clinical Oncology 2006;29:364-70. [DOI: 10.1097/01.coc.0000221428.35366.cb] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 286 |
Liengswangwong U, Karalak A, Morishita Y, Noguchi M, Khuhaprema T, Srivatanakul P, Miwa M. Immunohistochemical expression of mismatch repair genes: A screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2006; 12(23): 3740-3745 [PMID: 16773692 DOI: 10.3748/wjg.v12.i23.3740] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 287 |
van Leeuwen IM, Byrne HM, Jensen OE, King JR. Crypt dynamics and colorectal cancer: advances in mathematical modelling. Cell Prolif 2006;39:157-81. [PMID: 16671995 DOI: 10.1111/j.1365-2184.2006.00378.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 288 |
Kadiyska T, Goranova T, Dineva G, Nedin D, Alexandrova A, Gegova A, Kaneva R, Damyanov D, Kremensky I, Mitev V. Molecular screening for hereditary nonpolyposis colorectal cancer in Bulgaria. Open Medicine 2006;1:128-35. [DOI: 10.2478/s11536-006-0013-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 289 |
Lamberti C, Lundin S, Bogdanow M, Pagenstecher C, Friedrichs N, Büttner R, Sauerbruch T. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis 2007;22:145-52. [PMID: 16724208 DOI: 10.1007/s00384-006-0131-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 290 |
Fang JY, Lu R, Mikovits JA, Cheng ZH, Zhu HY, Chen YX. Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett. 2006;233:124-130. [PMID: 16473673 DOI: 10.1016/j.canlet.2005.03.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 291 |
Faber P, Fisch P, Waterhouse M, Schmitt-gräff A, Bertz H, Finke J, Spyridonidis A. Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans. Blood 2006;107:3389-96. [DOI: 10.1182/blood-2005-08-3431] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 292 |
Grady WM. Genomic instability and colorectal cancer. Curr colorectal cancer rep 2006;2:66-71. [DOI: 10.1007/s11888-006-0004-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 293 |
Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, Miyakura Y, Nagai H, Mano H. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 2006;25:139-46. [PMID: 16247484 DOI: 10.1038/sj.onc.1209009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 294 |
Grady WM, Willis JE, Trobridge P, Romero-Gallo J, Munoz N, Olechnowicz J, Ferguson K, Gautam S, Markowitz SD. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations. Int J Cancer 2006;118:600-8. [PMID: 16108056 DOI: 10.1002/ijc.21399] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 295 |
Raptis S, Bapat B. Genetic instability in human tumors. EXS 2006;:303-20. [PMID: 16383024 DOI: 10.1007/3-7643-7378-4_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 296 |
Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006;7:77-82. [PMID: 16389187 DOI: 10.1016/S1470-2045(05)70540-4] [Cited by in Crossref: 165] [Cited by in F6Publishing: 171] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 297 |
Ehrlich M. DNA methylation and cancer-associated genetic instability. Adv Exp Med Biol 2005;570:363-92. [PMID: 18727508 DOI: 10.1007/1-4020-3764-3_13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 298 |
Lynch J, Rustgi AK. Mechanisms of Gastrointestinal Malignancies. Physiology of the Gastrointestinal Tract 2006. [DOI: 10.1016/b978-012088394-3/50020-9] [Reference Citation Analysis]
|
| 299 |
Rodriguez-bigas MA, Chang GJ, Skibber JM. Surgical Implications of Colorectal Cancer Genetics. Surgical Oncology Clinics of North America 2006;15:51-66. [DOI: 10.1016/j.soc.2005.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 300 |
Grady WM. Epigenetic events in the colorectum and in colon cancer. Biochem Soc Trans 2005;33:684-8. [PMID: 16042574 DOI: 10.1042/BST0330684] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 301 |
Kim HC, Roh SA, Ga IH, Kim JS, Yu CS, Kim JC. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005;20:1920-6. [PMID: 16336454 DOI: 10.1111/j.1440-1746.2005.03943.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 302 |
Sanchez de Abajo A, de la Hoya M, van Puijenbroek M, Godino J, Díaz-rubio E, Morreau H, Caldes T. Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer? Oncogene 2006;25:2124-30. [DOI: 10.1038/sj.onc.1209233] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 303 |
Eaton AM, Sandler R, Carethers JM, Millikan RC, Galanko J, Keku TO. 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2023-9. [PMID: 16103455 DOI: 10.1158/1055-9965.EPI-05-0131] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 304 |
Kato N, Shibuya H, Fukase M, Tamura G, Motoyama T. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants. Hum Pathol 2006;37:48-53. [PMID: 16360415 DOI: 10.1016/j.humpath.2005.09.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 305 |
Zhang RM, Wang L, Chen GY, Mao B, Chang J, Zhang Y, Li TQ, Gong M, Wang YQ, Feng WJ. [Randomized controlled trial on haiguiyuyang capsule in the treatment of duodenal ulcer]. Sichuan Daxue Xuebao Yixueban. 2005;36:233-236. [PMID: 15807275 DOI: 10.1093/hmg/ddi113] [Cited by in Crossref: 356] [Cited by in F6Publishing: 377] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 306 |
Tzao C, Hsu HS, Sun GH, Lai HL, Wang YC, Tung HJ, Yu CP, Cheng YL, Lee SC. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2005;130:1371. [PMID: 16256791 DOI: 10.1016/j.jtcvs.2005.06.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 307 |
Lubomierski N, Plotz G, Wormek M, Engels K, Kriener S, Trojan J, Jungling B, Zeuzem S, Raedle J. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors. Cancer. 2005;104:952-961. [PMID: 16015629 DOI: 10.1002/cncr.21266] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 308 |
Yamada D, Kikuchi S, Williams YN, Sakurai-yageta M, Masuda M, Maruyama T, Tomita K, Gutmann DH, Kakizoe T, Kitamura T, Kanai Y, Murakami Y. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma. Int J Cancer 2006;118:916-23. [DOI: 10.1002/ijc.21450] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 309 |
Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst. 2005;97:1124-1132. [PMID: 16077070 DOI: 10.1093/jnci/dji204] [Cited by in Crossref: 269] [Cited by in F6Publishing: 293] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 310 |
Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P. Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005;23:4705-4712. [PMID: 16034045 DOI: 10.1200/jco.2005.05.180] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 311 |
Raut CP, Pawlik TM, Rodriguez-Bigas MA. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res. 2004;568:275-282. [PMID: 15542114 DOI: 10.1016/j.mrfmmm.2004.05.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 312 |
Kondo E, Gu Z, Horii A, Fukushige S. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol Cell Biol 2005;25:4388-96. [PMID: 15899845 DOI: 10.1128/MCB.25.11.4388-4396.2005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 313 |
Koinuma K, Kaneda R, Toyota M, Yamashita Y, Takada S, Choi YL, Wada T, Okada M, Konishi F, Nagai H. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter. Carcinogenesis. 2005;26:2078-2085. [PMID: 16033773 DOI: 10.1093/carcin/bgi184] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 314 |
Schulmann K, Mori Y, Croog V, Yin J, Olaru A, Sterian A, Sato F, Wang S, Xu Y, Deacu E, Berki AT, Hamilton JP, Kan T, Abraham JM, Schmiegel W, Harpaz N, Meltzer SJ. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology 2005;129:74-85. [PMID: 16012936 DOI: 10.1053/j.gastro.2005.04.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 315 |
Mccabe DC, Caudill MA. DNA Methylation, Genomic Silencing, and Links to Nutrition and Cancer. Nutrition Reviews 2005;63:183-95. [DOI: 10.1111/j.1753-4887.2005.tb00136.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 316 |
Sieber O, Heinimann K, Tomlinson I. Genomic stability and tumorigenesis. Semin Cancer Biol 2005;15:61-6. [PMID: 15613289 DOI: 10.1016/j.semcancer.2004.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 317 |
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-668. [PMID: 15342696 DOI: 10.1136/jmg.2004.020651] [Cited by in Crossref: 250] [Cited by in F6Publishing: 268] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 318 |
Parrella P, Scintu M, Prencipe M, Poeta ML, Gallo AP, Rabitti C, Rinaldi M, Tommasi S, Paradiso A, Schittulli F, Valori VM, Toma S, Altomare V, Fazio VM. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Letters 2005;222:75-81. [DOI: 10.1016/j.canlet.2004.08.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 319 |
Din FV, Stark LA, Dunlop MG. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Br J Cancer 2005;92:1137-43. [PMID: 15770215 DOI: 10.1038/sj.bjc.6602455] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 320 |
Shao C, Deng L, Chen Y, Kucherlapati R, Stambrook PJ, Tischfield JA. Mlh1 mediates tissue-specific regulation of mitotic recombination. Oncogene 2004;23:9017-24. [PMID: 15480418 DOI: 10.1038/sj.onc.1208148] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 321 |
Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol. 2005;96:531-538. [PMID: 15661247 DOI: 10.1016/j.ygyno.2004.10.039] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 322 |
Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 2005;97:103-15. [PMID: 15657340 DOI: 10.1093/jnci/dji010] [Cited by in Crossref: 207] [Cited by in F6Publishing: 216] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 323 |
Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-4642. [PMID: 15542813 DOI: 10.1200/jco.2004.07.151] [Cited by in Crossref: 797] [Cited by in F6Publishing: 840] [Article Influence: 41.9] [Reference Citation Analysis]
|
| 324 |
Jones LC, Tefferi A, Idos GE, Kumagai T, Hofmann WK, Koeffler HP. RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia. Oncogene 2004;23:7846-53. [PMID: 15361842 DOI: 10.1038/sj.onc.1207510] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 325 |
Clark AJ, Barnetson R, Farrington SM, Dunlop MG. Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam Cancer. 2004;3:85-91. [PMID: 15340258 DOI: 10.1023/B:FAME.0000039915.94550.cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 326 |
Li LC, Okino ST, Dahiya R. DNA methylation in prostate cancer. Biochim Biophys Acta 2004;1704:87-102. [PMID: 15363862 DOI: 10.1016/j.bbcan.2004.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 327 |
Yang G, Scherer SJ, Shell SS, Yang K, Kim M, Lipkin M, Kucherlapati R, Kolodner RD, Edelmann W. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. Cancer Cell. 2004;6:139-150. [PMID: 15324697 DOI: 10.1016/j.ccr.2004.06.024] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 328 |
Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004;3:28. [PMID: 15476557 DOI: 10.1186/1476-4598-3-28] [Cited by in Crossref: 106] [Cited by in F6Publishing: 121] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 329 |
Gasche C. Review article: the chemoprevention of colorectal carcinoma. Aliment Pharmacol Ther 2004;20 Suppl 4:31-5. [PMID: 15352891 DOI: 10.1111/j.1365-2036.2004.02045.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 330 |
Edelmann L, Edelmann W. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer. Am J Med Genet C Semin Med Genet. 2004;129C:91-99. [PMID: 15264277 DOI: 10.1002/ajmg.c.30021] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 331 |
Yan T, Desai AB, Jacobberger JW, Sramkoski RM, Loh T, Kinsella TJ. CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Molecular Cancer Therapeutics 2004;3:1147-1157. [DOI: 10.1158/1535-7163.1147.3.9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 332 |
Lei X, Zhu Y, Tomkinson A, Sun L. Measurement of DNA mismatch repair activity in live cells. Nucleic Acids Res. 2004;32:e100. [PMID: 15249596 DOI: 10.1093/nar/gnh098] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 333 |
Parker AR, Leonard CP, Hua L, Francis RO, Dhara S, Maitra A, Eshleman JR. A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents. Br J Cancer 2004;90:1666-71. [PMID: 15083201 DOI: 10.1038/sj.bjc.6601740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 334 |
Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143-153. [PMID: 14732866 DOI: 10.1038/nrc1279] [Cited by in Crossref: 1635] [Cited by in F6Publishing: 1721] [Article Influence: 86.1] [Reference Citation Analysis]
|
| 335 |
Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004;126:394-401. [PMID: 14762775 DOI: 10.1053/j.gastro.2003.12.023] [Cited by in Crossref: 347] [Cited by in F6Publishing: 367] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 336 |
Miyakura Y, Sugano K, Akasu T, Yoshida T, Maekawa M, Saitoh S, Sasaki H, Nomizu T, Konishi F, Fujita S, Moriya Y, Nagai H. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2004;2:147-56. [PMID: 15017620 DOI: 10.1016/s1542-3565(03)00314-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 85] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 337 |
Koinuma K, Shitoh K, Miyakura Y, Furukawa T, Yamashita Y, Ota J, Ohki R, Choi YL, Wada T, Konishi F. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer. 2004;108:237-242. [PMID: 14639609 DOI: 10.1002/ijc.11523] [Cited by in Crossref: 88] [Cited by in F6Publishing: 105] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 338 |
Genschel J, Modrich P. Mechanism of 5'-directed excision in human mismatch repair. Mol Cell 2003;12:1077-86. [PMID: 14636568 DOI: 10.1016/s1097-2765(03)00428-3] [Cited by in Crossref: 182] [Cited by in F6Publishing: 192] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 339 |
Guanti G. Genetic testing and surgeon decision. ACTA CHIR IUG 2004;51:57-60. [DOI: 10.2298/aci0402057g] [Reference Citation Analysis]
|
| 340 |
Wu T, Rashid A. Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer. Cancer Diagnostics 2004. [DOI: 10.1007/978-1-59259-791-8_20] [Reference Citation Analysis]
|
| 341 |
Faulkner RD, Seedhouse CH, Das-gupta EP, Russell NH. BAT-25 and BAT-26, two mononucleotide microsatellites, are not sensitive markers of microsatellite instability in acute myeloid leukaemia: BAT-25 and BAT-26 are not Sensitive to MSI in AML. British Journal of Haematology 2004;124:160-5. [DOI: 10.1046/j.1365-2141.2003.04750.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 342 |
Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J, MacDermot K, Sanders DS, Morreau H, Müller A, Oliani C, Orntoft T, Ponz De Leon M, Rosty C, Rodriguez-Bigas M, Rüschoff J, Ruszkiewicz A, Sabourin J, Salovaara R, Möslein G; ICG-HNPCC (International Collaborative Group). The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer 2001;1:87-92. [PMID: 14574003 DOI: 10.1023/a:1013840907881] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 343 |
Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9(12): 2642-2649 [PMID: 14669304 DOI: 10.3748/wjg.v9.i12.2642] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 100] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 344 |
Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2:41. [PMID: 14672538 DOI: 10.1186/1476-4598-2-41] [Cited by in Crossref: 118] [Cited by in F6Publishing: 129] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 345 |
Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA, Buller RE. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 2003;98:2199-206. [PMID: 14601090 DOI: 10.1002/cncr.11770] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 346 |
Meyers M, Hwang A, Wagner MW, Bruening AJ, Veigl ML, Sedwick WD, Boothman DA. A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage. Oncogene 2003;22:7376-88. [PMID: 14576845 DOI: 10.1038/sj.onc.1206941] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 347 |
Chan AS, Tsui WY, Chen X, Chu KM, Chan TL, Chan AS, Li R, So S, Yuen ST, Leung SY. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene. 2003;22:6946-6953. [PMID: 14534543 DOI: 10.1038/sj.onc.1206799] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 348 |
Ward RL, Cheong K, Ku SL, Meagher A, O'Connor T, Hawkins NJ. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol. 2003;21:3729-3736. [PMID: 14551292 DOI: 10.1200/jco.2003.03.123] [Cited by in Crossref: 152] [Cited by in F6Publishing: 163] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 349 |
Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003;107:53-9. [PMID: 12925956 DOI: 10.1002/ijc.11348] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 350 |
Scarisbrick JJ, Mitchell TJ, Calonje E, Orchard G, Russell-jones R, Whittaker SJ. Microsatellite Instability Is Associated with Hypermethylation of the hMLH1 Gene and Reduced Gene Expression in Mycosis Fungoides. Journal of Investigative Dermatology 2003;121:894-901. [DOI: 10.1046/j.1523-1747.2003.12496.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 351 |
Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci USA. 2003;100:8412-8417. [PMID: 12829793 DOI: 10.1073/pnas.1430846100] [Cited by in Crossref: 213] [Cited by in F6Publishing: 221] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 352 |
Dang DT, Chen X, Feng J, Torbenson M, Dang LH, Yang VW. Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 2003;22:3424-30. [PMID: 12776194 DOI: 10.1038/sj.onc.1206413] [Cited by in Crossref: 126] [Cited by in F6Publishing: 135] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 353 |
Halford SE, Rowan AJ, Lipton L, Sieber OM, Pack K, Thomas HJ, Hodgson SV, Bodmer WF, Tomlinson IP. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003;162:1545-8. [PMID: 12707038 DOI: 10.1016/S0002-9440(10)64288-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 98] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 354 |
Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003;162:1361-1371. [PMID: 12651628 DOI: 10.1016/s0002-9440(10)63932-6] [Cited by in Crossref: 121] [Cited by in F6Publishing: 141] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 355 |
Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 2003;105:204-9. [PMID: 12673680 DOI: 10.1002/ijc.11051] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 356 |
Arita M, Zhong X, Min Z, Hemmi H, Shimatake H. Multiple sites required for expression in 5'-flanking region of the hMLH1 gene. Gene 2003;306:57-65. [PMID: 12657467 DOI: 10.1016/s0378-1119(03)00385-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 357 |
Tycko B. Genetic and epigenetic mosaicism in cancer precursor tissues. Ann N Y Acad Sci. 2003;983:43-54. [PMID: 12724211 DOI: 10.1111/j.1749-6632.2003.tb05961.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 358 |
Popnikolov NK, Gatalica Z, Colome-grimmer MI, Sánchez RL. Loss of mismatch repair proteins in sebaceous gland tumors: Loss of MMR proteins in sebaceous gland tumors. Journal of Cutaneous Pathology 2003;30:178-84. [DOI: 10.1034/j.1600-0560.2003.00010.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 359 |
Kim SG, Chan AO, Wu TT, Issa JP, Hamilton SR, Rashid A. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. Gastroenterology 2003;124:1300-10. [PMID: 12730870 DOI: 10.1016/s0016-5085(03)00278-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 360 |
Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;21:1174-1179. [PMID: 12637487 DOI: 10.1200/jco.2003.04.060] [Cited by in Crossref: 499] [Cited by in F6Publishing: 538] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 361 |
Lynch JP, Hoops TC. The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 2002;16:775-810. [PMID: 12418049 DOI: 10.1016/s0889-8588(02)00029-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 362 |
Seitz S, Wa?muth P, Plaschke J, Schackert HK, Karsten U, Santibanez-koref M, Schlag PM, Scherneck S. Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosom Cancer 2003;37:29-35. [DOI: 10.1002/gcc.10196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 363 |
Bestor TH. Unanswered Questions about the Role of Promoter Methylation in Carcinogenesis. Annals of the New York Academy of Sciences 2003;983:22-7. [DOI: 10.1111/j.1749-6632.2003.tb05959.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 364 |
Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW, Baker SD, Zhao M, Weber JS. Phase I trial of continuous infusion 5-aza-2'-deoxycytidine. Cancer Chemother Pharmacol 2003;51:231-9. [PMID: 12655442 DOI: 10.1007/s00280-002-0563-y] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 365 |
Seedhouse CH, Das-Gupta EP, Russell NH. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Leukemia. 2003;17:83-88. [PMID: 12529664 DOI: 10.1038/sj.leu.2402747] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 366 |
Duval A, Hamelin R. Genetic instability in human mismatch repair deficient cancers. Ann Genet. 1995;45:71-75. [PMID: 12119215 DOI: 10.1016/s0003-3995(02)01115-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 367 |
Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol 2003; 9(1): 26-29 [PMID: 12508345 DOI: 10.3748/wjg.v9.i1.26] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 368 |
Peltomäki P. Deficient DNA Mismatch Repair in Carcinogenesis. Mechanisms in Carcinogenesis and Cancer Prevention 2003. [DOI: 10.1007/978-3-662-08602-5_7] [Reference Citation Analysis]
|
| 369 |
Mukai T, Sekiguchi M. Gene silencing in phenomena related to DNA repair. Oncogene 2002;21:9033-42. [DOI: 10.1038/sj.onc.1206095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 370 |
Miyakura Y, Sugano K, Konishi F, Fukayama N, Igarashi S, Kotake K, Matsui T, Koyama Y, Maekawa M, Nagai H. Methylation profile of theMLH1 promoter region and their relationship to colorectal carcinogenesis. Genes Chromosom Cancer 2003;36:17-25. [DOI: 10.1002/gcc.10134] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 371 |
Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nat Genet 2003;33:80-4. [PMID: 12447371 DOI: 10.1038/ng1052] [Cited by in Crossref: 147] [Cited by in F6Publishing: 157] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 372 |
Rush LJ, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Lett 2002;185:1-12. [PMID: 12142073 DOI: 10.1016/s0304-3835(02)00288-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 373 |
Miturski R, Bogusiewicz M, Ciotta C, Bignami M, Gogacz M, Burnouf D. Mismatch repair genes and microsatellite instability as molecular markers for gynecological cancer detection. Exp Biol Med (Maywood) 2002;227:579-86. [PMID: 12192099 DOI: 10.1177/153537020222700805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 374 |
Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845-860. [PMID: 12081733 DOI: 10.1046/j.1365-2168.2002.02120.x] [Cited by in Crossref: 425] [Cited by in F6Publishing: 457] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 375 |
Furukawa T, Konishi F, Masubuchi S, Shitoh K, Nagai H, Tsukamoto T. Densely methylatedMLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers. Genes Chromosom Cancer 2002;35:1-10. [DOI: 10.1002/gcc.10100] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 376 |
Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene. 2002;21:3864-3871. [PMID: 12032824 DOI: 10.1038/sj.onc.1205485] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 377 |
Li M, Wan W, Gu J. Detection of tumor mutant DNA in plasma of patient with colorectal cancer. Chin J Cancer Res 2002;14:154-156. [DOI: 10.1007/s11670-002-0034-3] [Reference Citation Analysis]
|
| 378 |
Trinh BN, Long TI, Nickel AE, Shibata D, Laird PW. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol Cell Biol 2002;22:2906-17. [PMID: 11940649 DOI: 10.1128/MCB.22.9.2906-2917.2002] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 379 |
Farrington SM, McKinley AJ, Carothers AD, Cunningham C, Bubb VJ, Sharp L, Wyllie AH, Dunlop MG. Evidence for an age-related influence of microsatellite instability on colorectal cancer survival. Int J Cancer 2002;98:844-50. [PMID: 11948461 DOI: 10.1002/ijc.10264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 380 |
Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell 2002;1:299-305. [DOI: 10.1016/s1535-6108(02)00061-2] [Cited by in Crossref: 215] [Cited by in F6Publishing: 232] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 381 |
Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, O'Connor T, Ward R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002;122:1376-87. [PMID: 11984524 DOI: 10.1053/gast.2002.32997] [Cited by in Crossref: 275] [Cited by in F6Publishing: 294] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 382 |
Terdiman JP, Levin TR, Allen BA, Gum JR Jr, Fishbach A, Conrad PG, Miller GA, Weinberg V, Bachman R, Bergoffen J, Stembridge A, Toribara NW, Sleisenger MH, Kim YS. Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology 2002;122:940-7. [PMID: 11910346 DOI: 10.1053/gast.2002.32537] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 383 |
Genschel J, Bazemore LR, Modrich P. Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair. Journal of Biological Chemistry 2002;277:13302-11. [DOI: 10.1074/jbc.m111854200] [Cited by in Crossref: 180] [Cited by in F6Publishing: 188] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 384 |
Deng G, Peng E, Gum J, Terdiman J, Sleisenger M, Kim YS. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Br J Cancer 2002;86:574-9. [PMID: 11870540 DOI: 10.1038/sj.bjc.6600148] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 385 |
Sakata K, Tamura G, Endoh Y, Ohmura K, Ogata S, Motoyama T. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability. Br J Cancer. 2002;86:564-567. [PMID: 11870538 DOI: 10.1038/sj.bjc.6600076] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 386 |
Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD. HLTF gene silencing in human colon cancer. Proc Natl Acad Sci U S A 2002;99:4562-7. [PMID: 11904375 DOI: 10.1073/pnas.062459899] [Cited by in Crossref: 119] [Cited by in F6Publishing: 122] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 387 |
Chen J, Chen Y, Wang Y, Tseng R, Chen C, Wang Y. Alterations of thep16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002;98:724-31. [DOI: 10.1002/ijc.10262] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 388 |
Humbert O, Hermine T, Hernandez H, Bouget T, Selves J, Laurent G, Salles B, Lautier D. Implication of protein kinase C in the regulation of DNA mismatch repair protein expression and function. J Biol Chem 2002;277:18061-8. [PMID: 11880362 DOI: 10.1074/jbc.M103451200] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 389 |
Li H, Myeroff L, Kasturi L, Krumroy L, Schwartz S, Willson JK, Stanbridge E, Casey G, Markowitz S. Chromosomal autonomy of hMLH1 methylation in colon cancer. Oncogene 2002;21:1443-9. [DOI: 10.1038/sj.onc.1205247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 390 |
Wheeler JM, Warren BF, Mortensen NJ, Kim HC, Biddolph SC, Elia G, Beck NE, Williams GT, Shepherd NA, Bateman AC, Bodmer WF. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002;50:218-23. [PMID: 11788563 DOI: 10.1136/gut.50.2.218] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 391 |
Chen S, Bigner SH, Modrich P. High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc Natl Acad Sci U S A 2001;98:13802-7. [PMID: 11717437 DOI: 10.1073/pnas.241508098] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 392 |
Schulmann K, Schmiegel W. Kolorektales Karzinom. Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen 2002. [DOI: 10.1007/978-3-642-56297-6_8] [Reference Citation Analysis]
|
| 393 |
Kuwada SK, Neklason DW, Burt RW. Biology and Molecular Genetics of Colorectal Cancer. Colorectal Cancer 2002. [DOI: 10.1007/978-1-59259-160-2_1] [Reference Citation Analysis]
|
| 394 |
Szadkowski M, Jiricny J. Identification and functional characterization of the promoter region of the humanMSH6 gene. Genes Chromosom Cancer 2002;33:36-46. [DOI: 10.1002/gcc.1211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 395 |
Deng G, Chen A, Pong E, Kim YS. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene. 2001;20:7120-7127. [PMID: 11704838 DOI: 10.1038/sj.onc.1204891] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 396 |
Goel A, Arnold CN, Boland CR. Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights. Gastroenterology 2001;121:1497-502. [PMID: 11729129 DOI: 10.1053/gast.2001.29978] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 397 |
Jubb AM, Bell SM, Quirke P. Methylation and colorectal cancer. J Pathol. 2001;195:111-134. [PMID: 11568897 DOI: 10.1002/path.923] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 398 |
Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001;121:830-8. [PMID: 11606497 DOI: 10.1053/gast.2001.27996] [Cited by in Crossref: 164] [Cited by in F6Publishing: 182] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 399 |
Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P, Hamelin R. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene. 2001;20:5025-5032. [PMID: 11526487 DOI: 10.1038/sj.onc.1204611] [Cited by in Crossref: 133] [Cited by in F6Publishing: 136] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 400 |
Fang JY, Xiao SD. Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 2001;16:960-8. [PMID: 11595058 DOI: 10.1046/j.1440-1746.2001.02554.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 401 |
Calin G, Ranzani GN, Amadori D, Herlea V, Matei I, Barbanti-Brodano G, Negrini M. Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype. BMC Genet 2001;2:14. [PMID: 11532193 DOI: 10.1186/1471-2156-2-14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 402 |
Ogata S, Tamura G, Endoh Y, Sakata K, Ohmura K, Motoyama T. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer. J Pathol. 2001;194:334-340. [PMID: 11439366 DOI: 10.1002/path.895] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 403 |
Menigatti M, Di Gregorio C, Borghi F, Sala E, Scarselli A, Pedroni M, Foroni M, Benatti P, Roncucci L, Ponz de Leon M, Percesepe A. Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. Genes Chromosomes Cancer 2001;31:357-61. [PMID: 11433526 DOI: 10.1002/gcc.1154] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 404 |
Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, Go MY, Chung SC, Sung JJ. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer. 2001;91:2294-2301. [PMID: 11413518 DOI: 10.1002/1097-0142(20010615)91:12%3C2294::AID-CNCR1261%3E3.0.CO;2-G] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 405 |
Potocnik U, Glavac D, Golouh R, Ravnik-Glavac M. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet. 2001;126:85-96. [PMID: 11376800 DOI: 10.1016/s0165-4608(00)00399-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 406 |
Peltomaki P. DNA mismatch repair and cancer. Mutat Res. 2001;488:77-85. [PMID: 11223406 DOI: 10.1016/s1383-5742(00)00058-2] [Cited by in Crossref: 114] [Cited by in F6Publishing: 125] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 407 |
Avidor B, Varon M, Marmor S, Lifschitz-mercer B, Kletter Y, Ephros M, Giladi M. DNA Amplification for the Diagnosis of Cat-Scratch Disease in Small-Quantity Clinical Specimens. Am J Clin Pathol 2001;115:900-9. [DOI: 10.1309/y5wn-8dfd-wlvt-kkad] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 408 |
Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, Hawkins N. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001;48:821-9. [PMID: 11358903 DOI: 10.1136/gut.48.6.821] [Cited by in Crossref: 249] [Cited by in F6Publishing: 252] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 409 |
Shteper PJ, Siegfried Z, Asimakopoulos FA, Palumbo GA, Rachmilewitz EA, Ben-Neriah Y, Ben-Yehuda D. ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL. Leukemia 2001;15:575-82. [PMID: 11368359 DOI: 10.1038/sj.leu.2402026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 410 |
Taverna P, Liu L, Hwang H, Hanson AJ, Kinsella TJ, Gerson SL. Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. Mutation Research/DNA Repair 2001;485:269-81. [DOI: 10.1016/s0921-8777(01)00076-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 411 |
Furihata M, Takeuchi T, Ohtsuki Y, Terao N, Kuwahara M, Shuin T. GENETIC ANALYSIS OF hMLH1 IN TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: PROMOTER METHYLATION OR MUTATION. Journal of Urology 2001;165:1760-4. [DOI: 10.1016/s0022-5347(05)66409-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 412 |
Tobias ES, Hurlstone AFL, Mackenzie E, Mcfarlane R, Black DM. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 2001;20:2844-53. [DOI: 10.1038/sj.onc.1204433] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 413 |
Furihata M, Takeuchi T, Ohtsuki Y, Terao N, Kuwahara M, Shuin T. GENETIC ANALYSIS OF hMLH1 IN TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: PROMOTER METHYLATION OR MUTATION. The Journal of Urology 2001. [DOI: 10.1097/00005392-200105000-00096] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 414 |
Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet. 2001;27:427-430. [PMID: 11279526 DOI: 10.1038/86934] [Cited by in Crossref: 335] [Cited by in F6Publishing: 345] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 415 |
Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001;116:246-53. [PMID: 11180000 DOI: 10.1046/j.1523-1747.2001.01233.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 416 |
Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000;2:20-28. [PMID: 11272898 DOI: 10.1016/s1525-1578(10)60611-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 115] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 417 |
Hawkins NJ, Tomlinson I, Meagher A, Ward RL. Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br J Cancer 2001;84:232-6. [PMID: 11161382 DOI: 10.1054/bjoc.2000.1554] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 418 |
Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol. 2001;13:63-69. [PMID: 11148689 DOI: 10.1097/00001622-200101000-00013] [Cited by in Crossref: 152] [Cited by in F6Publishing: 134] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 419 |
Shcherbakova PV, Hall MC, Lewis MS, Bennett SE, Martin KJ, Bushel PR, Afshari CA, Kunkel TA. Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol Cell Biol 2001;21:940-51. [PMID: 11154280 DOI: 10.1128/MCB.21.3.940-951.2001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 420 |
Pinto M, Oliveira C, Machado JC, Cirnes L, Tavares J, Carneiro F, Hamelin R, Hofstra R, Seruca R, Sobrinho-Simões M. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab Invest 2000;80:1915-23. [PMID: 11140703 DOI: 10.1038/labinvest.3780201] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 421 |
Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de la Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proceedings of the National Academy of Sciences 2001;98:591-6. [DOI: 10.1073/pnas.98.2.591] [Cited by in Crossref: 143] [Cited by in F6Publishing: 142] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 422 |
Yoon J, Dammann R, Pfeifer GP. Hypermethylation of the CpG island of theRASSF1A gene in ovarian and renal cell carcinomas. Int J Cancer 2001;94:212-7. [DOI: 10.1002/ijc.1466] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 423 |
Leung WK, Yu J, Ng EKW, To KF, Ma PK, Lee TL, Go MY, Chung SCS, Sung JJY. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001;91:2294-301. [DOI: 10.1002/1097-0142(20010615)91:12<2294::aid-cncr1261>3.0.co;2-g] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 424 |
Aquilina G, Bignami M. Mismatch repair in correction of replication errors and processing of DNA damage. J Cell Physiol 2001;187:145-54. [DOI: 10.1002/jcp.1067] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 425 |
Kawamura A, Adachi K, Ishihara S, Katsube T, Takashima T, Yuki M, Amano K, Fukuda R, Yamashita Y, Kinoshita Y. Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma. Cancer 2001;91:339-45. [DOI: 10.1002/1097-0142(20010115)91:2<339::aid-cncr1007>3.0.co;2-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 426 |
Maehara Y, Oda S, Sugimachi K. The instability within: problems in current analyses of microsatellite instability. Mutation Research/DNA Repair 2001;461:249-63. [DOI: 10.1016/s0921-8777(00)00061-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 427 |
Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA. 2001;98:591-596. [PMID: 11120891 DOI: 10.1073/pnas.011528698] [Cited by in Crossref: 40] [Cited by in F6Publishing: 102] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 428 |
Yang P, Cunningham JM, Halling KC, Lesnick TG, Burgart LJ, Wiegert EM, Christensen ER, Lindor NM, Katzmann JA, Thibodeau SN. Higher Risk of Mismatch Repair-Deficient Colorectal Cancer in α1-Antitrypsin Deficiency Carriers and Cigarette Smokers. Molecular Genetics and Metabolism 2000;71:639-45. [DOI: 10.1006/mgme.2000.3089] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 429 |
Wheeler JM, Loukola A, Aaltonen LA, Mortensen NJ, Bodmer WF. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet 2000;37:588-92. [PMID: 10922385 DOI: 10.1136/jmg.37.8.588] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 430 |
Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000;119:854-65. [PMID: 10982779 DOI: 10.1053/gast.2000.16507] [Cited by in Crossref: 273] [Cited by in F6Publishing: 281] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 431 |
Wheeler JM, Bodmer WF, Mortensen NJ. DNA mismatch repair genes and colorectal cancer. Gut 2000;47:148-53. [PMID: 10861278 DOI: 10.1136/gut.47.1.148] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 432 |
Widschwendter M, Berger J, Hermann M, Müller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst. 2000;92:826-832. [PMID: 10814678 DOI: 10.1093/jnci/92.10.826] [Cited by in Crossref: 198] [Cited by in F6Publishing: 207] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 433 |
Jiricny J, Nyström-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev. 2000;10:157-161. [PMID: 10753784 DOI: 10.1016/s0959-437x(00)00066-6] [Cited by in Crossref: 167] [Cited by in F6Publishing: 184] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 434 |
Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomäki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol. 2000;156:1773-1779. [PMID: 10793088 DOI: 10.1016/s0002-9440(10)65048-1] [Cited by in Crossref: 198] [Cited by in F6Publishing: 178] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 435 |
Markowitz S. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000;1470:M13-20. [PMID: 10656986 DOI: 10.1016/s0304-419x(99)00031-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 436 |
Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol 2000;183:145-54. [PMID: 10737890 DOI: 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V] [Cited by in Crossref: 278] [Cited by in F6Publishing: 292] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 437 |
Chen WD, Eshleman JR, Aminoshariae MR, Ma AH, Veloso N, Markowitz SD, Sedwick WD, Veigl ML. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells. J Natl Cancer Inst 2000;92:480-5. [PMID: 10716966 DOI: 10.1093/jnci/92.6.480] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 438 |
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000;28:E32. [PMID: 10734209 DOI: 10.1093/nar/28.8.e32] [Cited by in Crossref: 1008] [Cited by in F6Publishing: 1088] [Article Influence: 43.8] [Reference Citation Analysis]
|
| 439 |
Kanamori M, Kon H, Nobukuni T, Nomura S, Sugano K, Mashiyama S, Kumabe T, Yoshimoto T, Meuth M, Sekiya T, Murakami Y. Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene. Oncogene 2000;19:1564-71. [DOI: 10.1038/sj.onc.1203454] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 440 |
Pao MM, Liang G, Tsai YC, Xiong Z, Laird PW, Jones PA. DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines. Oncogene 2000;19:943-52. [DOI: 10.1038/sj.onc.1203414] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 441 |
Berney CR, Fisher RJ, Yang J, Russell PJ, Crowe PJ. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer 2000;89:1-7. [DOI: 10.1002/(sici)1097-0215(20000120)89:1<1::aid-ijc1>3.0.co;2-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 442 |
Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801-818. [PMID: 10544223 DOI: 10.1136/jmg.36.11.801] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 443 |
Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H, Jones DA. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc Natl Acad Sci U S A 1999;96:14007-12. [PMID: 10570189 DOI: 10.1073/pnas.96.24.14007] [Cited by in Crossref: 148] [Cited by in F6Publishing: 157] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 444 |
Bevilacqua RA, Simpson AJ. Methylation of thehMLH1 promoter but nohMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer 2000;87:200-3. [DOI: 10.1002/1097-0215(20000715)87:2<200::aid-ijc7>3.0.co;2-i] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 445 |
Grady WM, Markowitz S. Genomic instability and colorectal cancer. Curr Opin Gastroenterol 2000;16:62-7. [PMID: 17024019 DOI: 10.1097/00001574-200001000-00012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 446 |
Medhioub M, Vaury C, Hamelin R, Thomas G. Lack of somatic mutation in the coding sequence ofSIAH1 in tumors hemizygous for this candidate tumor suppressor gene. Int J Cancer 2000;87:794-7. [DOI: 10.1002/1097-0215(20000915)87:6<794::aid-ijc5>3.0.co;2-b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 447 |
Herman JG, Baylin SB. Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 2000;249:35-54. [PMID: 10802937 DOI: 10.1007/978-3-642-59696-4_3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 82] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 448 |
Kuismanen SA, Holmberg MT, Salovaara R, Schweizer P, Aaltonen LA, de La Chapelle A, Nyström-Lahti M, Peltomäki P. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci U S A 1999;96:12661-6. [PMID: 10535979 DOI: 10.1073/pnas.96.22.12661] [Cited by in Crossref: 85] [Cited by in F6Publishing: 94] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 449 |
Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, Herman JG. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999;155:1767-72. [PMID: 10550333 DOI: 10.1016/S0002-9440(10)65492-2] [Cited by in Crossref: 230] [Cited by in F6Publishing: 182] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 450 |
Ellenson LH. hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence? Am J Pathol 1999;155:1399-402. [PMID: 10550292 DOI: 10.1016/S0002-9440(10)65451-X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 451 |
Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst. 1999;91:1295-1303. [PMID: 10433618 DOI: 10.1093/jnci/91.15.1295] [Cited by in Crossref: 282] [Cited by in F6Publishing: 313] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 452 |
Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ, Bodmer WF. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc Natl Acad Sci U S A 1999;96:10296-301. [PMID: 10468602 DOI: 10.1073/pnas.96.18.10296] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 453 |
Sedwick W, Markowitz SD, Veigl ML. Mismatch repair and drug responses in cancer. Drug Resistance Updates 1999;2:295-306. [DOI: 10.1054/drup.1999.0099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 454 |
Herman JG. Hypermethylation of tumor suppressor genes in cancer. Seminars in Cancer Biology 1999;9:359-67. [DOI: 10.1006/scbi.1999.0138] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 455 |
Matzke M, Scheid OM, Matzke A. Rapid structural and epigenetic changes in polyploid and aneuploid genomes. Bioessays 1999;21:761-7. [DOI: 10.1002/(sici)1521-1878(199909)21:9<761::aid-bies7>3.0.co;2-c] [Cited by in Crossref: 97] [Cited by in F6Publishing: 110] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 456 |
Nicholl ID, Dunlop MG. Molecular Markers of Prognosis in Colorectal Cancer. JNCI Journal of the National Cancer Institute 1999;91:1267-9. [DOI: 10.1093/jnci/91.15.1267] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 457 |
Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DJ, Kovatich AJ, Palazzo JP, Fishel R, Goodfellow PJ. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 1999;8:661-6. [PMID: 10072435 DOI: 10.1093/hmg/8.4.661] [Cited by in Crossref: 208] [Cited by in F6Publishing: 227] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 458 |
Shcherbakova PV, Kunkel TA. Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol 1999;19:3177-83. [PMID: 10082584 DOI: 10.1128/MCB.19.4.3177] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 459 |
Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, Akiyama Y, Sugano S, Yuasa Y, Maruyama K. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun. 1999;256:488-494. [PMID: 10080925 DOI: 10.1006/bbrc.1999.0368] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 460 |
Mcburney MW. Gene Silencing in the Development of Cancer. Experimental Cell Research 1999;248:25-9. [DOI: 10.1006/excr.1999.4454] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 461 |
Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999;21:163-167. [PMID: 9988266 DOI: 10.1038/5947] [Cited by in Crossref: 1647] [Cited by in F6Publishing: 1753] [Article Influence: 68.6] [Reference Citation Analysis]
|
| 462 |
Jiricny J. Eukaryotic mismatch repair: an update. Mutat Res 1998;409:107-21. [PMID: 9875287 DOI: 10.1016/s0921-8777(98)00056-1] [Cited by in Crossref: 91] [Cited by in F6Publishing: 100] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 463 |
Jiricny J. Replication errors: cha(lle)nging the genome. EMBO J. 1998;17:6427-6436. [PMID: 9822589 DOI: 10.1093/emboj/17.22.6427] [Cited by in Crossref: 134] [Cited by in F6Publishing: 152] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 464 |
Rüschoff J, Dietmaier W, Beyser K, Beham A, Bocker T, Kullmann F. Aktuelles vom HNPCC. Ökosystem Darm VIII 1999. [DOI: 10.1007/978-3-642-59963-7_5] [Reference Citation Analysis]
|
| 465 |
Pegg AE. DNA Repair Pathways and Cancer Prevention. In: Zappia V, Della Ragione F, Barbarisi A, Russo GL, Iacovo RD, editors. Advances in Nutrition and Cancer 2. Boston: Springer US; 1999. pp. 253-67. [DOI: 10.1007/978-1-4757-3230-6_22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 466 |
[DOI: 10.1101/662262] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
|
